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ABSTRACT 
Homocysteine (Hcy) is metabolized through a series of remethylation and 
transsulphuration processes that require the co-factors vitamins B6, folate (the nutrient derived 
from food, and folic acid is supplemental), and B12.  Homocysteine metabolism results in the 
production of creatine (Cr).  By way of negative feedback creatine supplements could potentially 
decrease Hcy production.  Low dietary intake of vitamins and creatine, often a consequence of a 
vegetarian diet may also increase serum Hcy concentrations.  It was therefore the purpose of this 
study to examine the effect of a five day creatine loading period (0.25 g Cr/kg lean body mass 
(LBM)/day) in female vegetarians (VG) (n=9, age 25 ± 3.6) and non-vegetarians (NV) (n=11, 
age 24 ± 5.9) on serum levels of Hcy, vitamins B6 and B12, whole blood folate, and on a number 
of fitness measures known to be positively affected by creatine supplementation: peak torque and 
average power during leg extensions; one repetition maximum (1RM) bench and leg press; peak 
power during repeated Wingate anaerobic tests.  Aside from a difference in change scores for leg 
press, there were no differences between dietary groups for the fitness measures, and therefore 
the participants were pooled for comparisons between time points.  Urinary creatine was 
significantly greater following the five day loading period (81 ± 113 vs. 647 ± 421 µmol).  In 
contrast, urinary creatinine did not change.  A significant increase in plasma vitamin B6 
(pyridoxal 5‟-phosphate) was found (72 ± 24 vs. 94 ± 24 nmol/L) (p < 0.05), although there were 
no between group differences.  Serum Hcy, vitamin B12, and whole blood folate levels did not 
change significantly over time in either group.  Participants showed significant increases post-
loading in bench press (45 ± 13 vs. 48 ± 12 kg.) and leg press (116 ± 35 vs. 125 ± 40 kg) (p < 
0.05).  Changes scores for leg press were greater for the vegetarian participants when compared 
with non-vegetarians (16 ± 16 vs. 3 ± 9 kg).  Significant improvements post-loading were also 
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noted for peak torque (85.0 ± 15.0 vs. 91.8 ± 12.9 Nm) and average power (99.5 ± 14.4 vs. 107.1 
± 14.8 W) (p < 0.05).  Peak power during repeated Wingate anaerobic tests also significantly 
improved in response to the intervention (449.2 ± 92.6 vs. 472.4 ± 103.5 W) (p < 0.05).  This 
response did not differ however between the two diet groups. These results suggest that a five 
day creatine loading protocol similarly affects fitness performance measures in both vegetarians 
and non-vegetarians.  There was no significant effect of the supplementation protocol on serum 
Hcy concentration, suggesting that the supplemented creatine did not decrease the reformation of 
Hcy, as originally hypothesized. 
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1. INTRODUCTION 
Homocysteine (Hcy) is a sulphur containing amino acid that is created during the 
production of methionine (Refsum, Ueland, Nygard, & Vollset, 1998).  Past research has linked 
plasma Hcy concentration with a variety of disease states, including cystathionine β-synthase 
(CBS) deficiencies (Mudd, Levy, & Skovby, 1995), renal (Mudd et al., 1995) and cardiovascular 
disease (Refsum et al., 1998).  Much of the research examining Hcy in disease states has 
identified altered metabolism of Hcy resulting in elevated Hcy levels as being a key factor in the 
pathogenetic characteristics of the disease. 
Plasma and serum concentrations of Hcy are altered by a number of lifestyle factors, 
including physical activity, dietary intake and nutritional status, gender and hormones 
(Chrysohoou et al., 2004).  Both gender and hormone status are linked with serum Hcy 
concentration, with older men generally having elevated concentrations when compared to 
women of a similar age and to younger populations.  Furthermore, postmenopausal women 
possess greater concentrations when compared to premenopausal or pregnant counterparts, 
suggesting that increases in female steroid hormones may have a diminishing effect on Hcy 
concentration (Chrysohoou et al., 2004). 
Dietary intake and nutritional status are also closely linked with serum Hcy 
concentration, because Hcy metabolism is dependent on sufficient intake and blood levels of a 
number of vitamins, including vitamins B2, B6, B12 and folate
1
 (Refsum et al., 1998).  A 
significant link between elevated Hcy concentrations in the bloodstream and cardiovascular 
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disease has been established (Refsum et al., 1998; Selhub, 1999).  It is thought that the presence 
of the amino acid in the bloodstream may damage the vascular system (Nygard et al., 1995; 
Selhub, 1999; Virtanen et al., 2005).  Possible solutions to this problem of elevated Hcy 
concentrations include vitamin (Bonaa et al., 2006; Jacques, Selhub, Bostom, Wilson, & 
Rosenberg, 1999; Lonn et al., 2006; Miller et al., 1992; Nygard, Refsum, Ueland, & Vollset, 
1998; Nygard et al., 1995; Refsum et al., 1998) and creatine (Cr) supplementation (Korzun, 
2004; Stead, Au, Jacobs, Brosnan, & Brosnan, 2001; Steenge, Verhoef, & Greenhaff, 2001; 
Taes, 2005; Taes et al., 2004; Taes et al., 2003). 
In the metabolism of Hcy, methionine is converted to S-adenosyl methionine (SAM), a 
methyl donor to a number of acceptors.  These methylation reactions result in the methylated 
substrate and S-adenosyl homocysteine (SAH).  S-adenosyl homocysteine is then metabolized to 
form Hcy.  Excess Hcy production leads to its exportation and subsequent increase in the 
bloodstream (Selhub, 1999). 
An important element in the reformation of Hcy is creatine.  One methyl acceptor in the 
transfer from SAM is guanidinoacetate, which results in the production of creatine (Taes et al., 
2003).  The production of creatine in vivo accounts for 70 % of the transmethylation reactions in 
the body, with the donation of a methyl group by SAM to guanidinoacetate in the liver (Taes, 
2005).  The role of oral creatine supplementation, a relatively popular sport supplement, in Hcy 
metabolism has been investigated, with mixed results.  Of the few studies looking specifically at 
the effects of creatine supplementation on Hcy concentration, some have shown that creatine has 
a lowering effect on Hcy (Korzun, 2004; Stead et al., 2001; Taes et al., 2003) while others have 
shown no effect (Steenge et al., 2001; Taes, 2005; Taes et al., 2004).  These previous researchers 
have attempted to determine whether oral supplementation with creatine monohydrate reduces 
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the need for the methylation of guanidinoacetate, thereby decreasing the frequency of Hcy 
reformation.  Due to the contrasting results found in both animal and human studies, further 
research should be performed to determine the effect of creatine supplementation on Hcy 
concentration in the bloodstream in humans. 
Vegetarians generally have very little natural creatine in their diet, because creatine is 
found mainly in animal products (Greenhaff, Bodin, Soderlund, & Hultman, 1994).  Considering 
the role of creatine in Hcy metabolism, it is likely that a vegetarian would have higher baseline 
concentrations of Hcy in her bloodstream, since the need for endogenous production of creatine 
would be great.  By supplementing with creatine monohydrate, this need for endogenous 
production could decrease, thereby decreasing the amount of Hcy produced. 
Creatine monohydrate is commonly used both as an ergogenic aid in high intensity sports 
and exercise, and to help increase lean tissue mass (Buford et al., 2007).  Creatine is required for 
the formation of phosphocreatine which is required for the rephosphorylation of adenosine 
diphosphate (ADP) to form adenosine triphosphate (ATP) during exercise and recovery.  By 
increasing the amount of creatine available, stored as phosphocreatine, the amount of energy 
generated during high intensity bouts of exercise may be increased (Harris, Soderlund, & 
Hultman, 1992). 
Individuals with lower baseline concentrations of total muscle creatine experience greater 
increases in this measure in response to supplementation (Burke et al., 2003; Syrotuik & Bell, 
2004).  Vegetarians, who should have a lower baseline concentration of total muscle creatine due 
to the lack of natural creatine intake in their diet, may experience a significantly greater 
absorption when supplementing orally.  Also, vegetarians may experience greater improvements 
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in physiological performance in response to oral supplementation, as they possibly would have a 
greater increase in muscle phosphocreatine available to them during high intensity activity 
(Burke et al., 2003). 
The effects of creatine supplementation on exercise have been investigated thoroughly, 
though few researchers have studied creatine supplementation and vegetarianism (Burke et al., 
2003; Harris et al., 1992; Lukaszuk et al., 2002; Lukaszuk, Robertson, Arch, & Moyna, 2005; 
MacCormick, Hill, MacNeil, Burke, & Smith-Palmer, 2004; Shomrat, Weinstein, & Katz, 2000), 
and none have focused on female vegetarians, fitness, and creatine supplementation.  A need for 
information in this area is evident in order to determine whether this population is at risk for 
elevated concentrations of Hcy in the bloodstream.  Also, determining whether supplementation 
with creatine monohydrate would be beneficial as a treatment to decrease Hcy concentration by 
decreasing the need for endogenous production of creatine is important. 
The current study investigated baseline concentration of Hcy in the bloodstream of 
vegetarian and non-vegetarian females, as well as the effect of creatine supplementation on this 
measure.  It was hypothesized that vegetarians would have higher concentration of Hcy at the 
onset of the study, and that creatine supplementation would result in a decrease in Hcy in the 
bloodstream.  As a secondary purpose, measures of muscle strength, power and anaerobic 
capacity were taken at the onset of the study as well as following the five day creatine loading 
intervention in order to determine whether supplementation created a response, and if the 
response differed between vegetarians and non-vegetarians. 
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2. SCIENTIFIC FRAMEWORK 
2.1 Literature Review 
2.1.1 Homocysteine 
Homocysteine is a non-protein forming sulphur amino acid that is found in the 
bloodstream (Nygard et al., 1995; Virtanen et al., 2005). Although reported ranges vary 
significantly (Refsum et al., 1998) normal concentrations of Hcy typically range from five to 15 
µmol/L. 
2.1.1.1 Homocysteine metabolism 
The metabolism of Hcy occurs primarily through two pathways; remethylation to 
methionine and transsulphuration to cystathionine (refer to Figure 1).  Methionine is an amino 
acid that is involved in protein synthesis (Allen, Stabler, Savage, & Lindenbaum, 1993), and is 
therefore of importance to the body.  In the presence of excess methionine, Hcy is directed to the 
transsulphuration pathway, and is thus catabolized to form cystathionine and then cysteine for 
disposal (Refsum et al., 1998).  The remethylation pathway requires vitamins B2 (riboflavin), B12 
and folate (B9) in order to proceed, while the transsulphuration pathway requires vitamin B6 in 
order to progress optimally (Refsum et al., 1998; Selhub, 1999). 
The transsulphuration pathway occurs when methionine supply is plentiful (Refsum et 
al., 1998).  Homocysteine reacts with serine to form cystathionine which is further metabolized 
to form cysteine (Refsum et al., 1998; Taes et al., 2003).  This occurs in the presence of CBS, 
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which is dependent on vitamin B6 (Refsum et al., 1998).
 
Figure 1.  Homocysteine metabolism.  Abbreviations: THF, tetrahydrofolate; 5CH3-THF, 5-
methyltetrahydrofolate; 5, 10-CH2-THF, 5, 10-methylene tetrahydrofolate; Ser, serine; Gly, 
glycine, AGAT, arginine:glycine amidinotransferase.  Modified from Taes et al., 2003. 
 
In the remethylation pathway, Hcy is methylated by 5-methyltetrahydrofolate which 
forms methionine, using vitamin B12 as a cofactor, and 5-methyltetrahydrofolate as a substrate 
(Korzun, 2004; Selhub, 1999).  5-methyltetrahydrofolate, upon giving up its methyl group, forms 
tetrahydrofolate (THF), which then reacts to form 5, 10-methylene tetrahydrofolate.  This multi-
step folate cycle concludes with the reproduction of 5-methyltetrahydrofolate (Taes et al., 2003) 
in the presence of methylene tetrahydrofolate reductase (MTHFR), which is dependent on the 
presence of vitamin B2 (Refsum et al., 1998).  Methionine is then activated to form SAM, which 
is a methyl donor to a variety of acceptors (Selhub, 1999), including guanidinoacetate, resulting 
in the formation of creatine (Taes et al., 2003).  The use of methyl groups is predominantly 
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directed towards the formation of creatine (Mudd et al., 1995).   SAM is reduced to form SAH, 
which is then hydrolyzed to regenerate Hcy (Selhub, 1999). 
2.1.1.2 Control and regulation of homocysteine metabolism 
The determination of the fate of Hcy within the cell is mediated by the dietary 
concentration of methionine: a)
 
when dietary methionine is high, it is quickly converted to SAM, 
which inhibits MTHFR activity (multi-step folate cycle) and activates CBS (transsulphuration 
pathway), causing an increase in the catabolism of Hcy; b)
 
when dietary methionine is low, SAM 
concentrations are too low to inhibit MTHFR activity or to activate the transsulphuration 
pathway, which encourages the remethylation pathway via an increase in the availability of 
substrate for remethylation (Selhub, 1999). 
The reactions of the remethylation and transsulphuration pathways are dependent on the 
availability of various vitamins (B2, B6, B12 and folate) (Selhub, 1999).  Therefore, the absence 
or limited amount of any one of the vitamins involved could have a detrimental effect on Hcy 
metabolism.  A well balanced diet that includes each of these vitamins is very important for Hcy 
metabolism and the resulting protein synthesis. 
Decreased availability of vitamin B2 limits the number of methyl groups available to 
remethylate Hcy and reform methionine.  Without vitamin B6, the transsulphuration pathway will 
not proceed optimally and in times of excess methionine availability, Hcy catabolism may be 
affected.  Deficiencies of folate would limit the multi-step folate cycle, and decrease methyl 
group availability to react with Hcy to form methionine.  In the absence of vitamin B12, this 
remethylation cannot take place, even in the presence of a methyl group and Hcy. 
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2.1.2 Factors affecting homocysteine concentration 
Homocysteine concentration is affected by a number of genetic and lifestyle factors.  The 
accumulation of Hcy in plasma, or hyperhomocysteinemia, typically results from a disruption of 
Hcy metabolism.  This alteration in metabolism precipitates the release of excess Hcy from the 
cells into the bloodstream to prevent toxicity within the cell (Selhub, 1999).  Severe cases of 
hyperhomocysteinemia are generally associated with genetic defects (Selhub, 1999), while mild 
to moderate hyperhomocysteinemia (plasma Hcy levels greater than 14 µmol/L) has been linked, 
although not causally, with a number of health problems/diseases. 
2.1.2.1 Cystathionine β-synthase deficiency 
A deficiency or defect of CBS is the most common disorder that inhibits the 
transsulphuration pathway (Mudd et al., 1995).  In such impairments, Hcy is diverted toward the 
remethylation pathway, thus increasing the rate of methionine synthesis, resulting in an increase 
in SAM concentration within the cell (Selhub, 1999).  Eventually, SAM concentration will reach 
levels associated with MTHFR inhibition (Selhub, 1999), which when coupled with the 
dysfunction of the transsulphuration pathway, causes a buildup of intracellular and then plasma 
Hcy concentration (Mudd et al., 1995). 
This genetic disorder results in a number of clinical abnormalities, such as: vision 
problems; osteoporosis, generally of the spine and the long bones; problems with reproductive 
fitness; central nervous system irregularities, such as mental retardation, neurologic and 
psychiatric abnormalities; and abnormalities of the vascular system, including 
thromboembolisms (McLean et al., 2004; Mudd et al., 1995).  Whether creatine supplementation 
has an effect on these disorders is unknown. 
9 
 
2.1.2.2 Renal disease/insufficiency 
Individuals with renal disease often have impaired excretion of Hcy resulting in mild to 
moderate hyperhomocysteinemia (Mudd et al., 1995). Bostom and Culleton (1999) reported that 
83 % of dialysis patients had fasting Hcy concentrations greater than 13.9 µmol/L. This increase 
in Hcy increases the risk of developing cardiovascular disease in this population. Bostom and 
Culleton (1999) state that while end stage renal disease patients do have a higher prevalence of 
cardiovascular disease risk factors such as old age or inactivity, there are also risk factors that are 
directly related to renal disease, such as elevations of Hcy concentration.  Individuals with end 
stage renal disease have a much greater risk of developing cardiovascular disease, and 
experience mortality related to cardiovascular disease 10 to 20 times more frequently than the 
general population (Bostom & Culleton, 1999). 
2.1.2.3 Cardiovascular disease 
Suggestions have been made stating that increased Hcy concentration in plasma may 
cause vascular lesions in connective tissue and smooth muscle cells, endothelial cells, and in 
vessel walls (Refsum et al., 1998).  This may affect the blood coagulation system (Selhub, 1999) 
and could have detrimental effects on vascular tissue (Nygard et al., 1995; Selhub, 1999; 
Virtanen et al., 2005).  It is in this way that the accumulation of Hcy may be linked to 
cardiovascular disease (Selhub, 1999). 
The Hordaland Homocysteine study reveals a number of factors that are associated with 
increases in Hcy concentration (Nygard et al., 1995).  This study included 16,176 individuals 
randomly selected from the National Population Registry in Western Norway who had not 
previously been diagnosed with coronary heart disease, cerebrovascular disease, hypertension, or 
diabetes.  In this publication, Nygard and colleagues (1995) reported that increases in plasma 
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Hcy were associated with several clinical variables that have been linked with cardiovascular 
disease, such as smoking, cholesterol levels, blood pressure, heart rate, and decreased levels of 
physical activity in men and women.  Early research noted that in individuals with CBS 
deficiencies who have experienced major atherothrombotic events, receiving treatments designed 
to decrease Hcy concentration decreased the rate of atherothrombotic events (Mudd et al., 1985; 
Wilcken & Wilcken, 1997).  Hcy lowering treatments also reduce the rate of progression of 
extracranial carotid artery plaque area (Peterson & Spence, 1998), while treatments designed to 
increase Hcy concentration (oral L-methionine load) elicit a reduction in flow-mediated brachial 
artery reactivity (Chambers, McGregor, Jean-Marie, & Kooner, 1997).  However, more recent 
investigations have revealed that decreases in plasma Hcy concentrations do not diminish the 
occurrence of cardiovascular events in individuals with previous histories of cardiovascular 
problems or disease (Bonaa et al., 2006; Lonn et al., 2006). 
Bonaa and colleagues (2006) randomly assigned 3,749 men and women who had 
previously experienced an acute myocardial infarction in the seven previous days to four 
treatment groups: a) folic acid, vitamin B12, and vitamin B6; b) folic acid and vitamin B12; c) 
vitamin B6; d) and a placebo group.  The participants were followed for 40 months, and 
incidence of a recurrent myocardial infarction, stroke or death due to coronary artery disease was 
recorded.  While Hcy concentration decreased in response to treatment a and b, occurrences of 
further myocardial events were not decreased.  The authors even found a trend towards an 
increase in myocardial events following the supplementation protocols, and recommend that 
such therapy should not be recommended following a myocardial event. 
Lonn and colleagues (2006) randomly assigned 5,522 men and women with vascular 
disease or diabetes to two treatment groups: folic acid, vitamin B6 and vitamin B12; or placebo.  
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Participants were supplemented for an average of five years.  The researchers were interested in 
death from cardiovascular causes, myocardial infarction, and stroke.  In spite of a decrease in 
plasma Hcy concentration (- 2.4 µmol/L), the treatment did not decrease the risk of death from 
cardiovascular causes or myocardial infarction.  There were fewer strokes in the supplement 
group when compared to the active treatment (4.0 vs. 5.3 %), and more participants in the 
supplement group had unstable angina (9.7 vs. 7.9 %).  The authors suggested that these 
differences were due to either an overestimate of the real effect, or to chance. 
Though no causal relationship has been proven, elevated total Hcy pool is a strong 
predictor of cardiovascular mortality.  A graded dose response association was found between 
plasma Hcy concentration and overall mortality in older adults with a previous history of 
coronary heart disease (Nygard et al., 1997).  This relationship was strongest for plasma Hcy 
levels greater than 15 µmol/L.  Also, Boushey, Beresford, Omenn, and Motulsky (1995) reported 
that a 5 µmol/L increase in total Hcy plasma levels was associated with an increased risk of 
coronary heart disease of 60 % for men and 80 % for women. 
In light of current and past literature, whether otherwise healthy individuals with 
increased plasma Hcy concentrations would benefit from decreasing these concentrations is 
unclear.  By minimizing plasma Hcy concentration in individuals with high levels initially, there 
may be a decrease in the risk of developing cardiovascular disease, before a cardiovascular event 
has occurred.  Therefore, determining ways to decrease Hcy in plasma is of great importance. 
2.1.2.4 Lifestyle factors affecting homocysteine 
Baseline Hcy concentration differs between males and females, and is altered in response 
to several manageable lifestyle choices such as dietary habits, differences in vitamin status, 
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physical activity level, medications (e.g. oral contraceptives) and smoking status, to highlight a 
few key factors. 
Smoking: Smoking, on its own, has been reported to cause vascular damage in a number 
of ways, including by injuring the arterial endothelium and promoting atherogenesis (Powell, 
1998).  A dose-response relationship between the number of cigarettes smoked and plasma Hcy 
concentration has been reported (Chrysohoou et al., 2004).  While the corresponding increase in 
Hcy concentration for every 10 cigarettes smoked daily was less for females when compared to 
males (0.3 vs. 0.7 µmol/L), the increases were significant for both genders (p = 0.01). 
Another study reported that smokers with modestly increased plasma Hcy concentration 
(greater than12 µmol/L) had a 12-fold increase in risk of cardiovascular disease when compared 
to non-smokers who had normal plasma Hcy concentration (less than 12 µmol/L) (O‟Callaghan, 
Meleady, Fitzgerald, & Graham, 2002).  This risk was also found to be greater in men.  The 
authors suggest that due to the aforementioned risk of cardiovascular disease currently associated 
with smoking and with increased Hcy concentration separately, the interaction of the two 
conditions would likely produce damage to the vascular system. 
In a study examining 16,176 individuals randomly selected from the National Population 
Registry in Western Norway, Nygard et al. (1995) noted that smokers had higher plasma Hcy 
concentrations than non-smokers of the same age, and that there was an almost linear increase in 
Hcy as the number of cigarettes smoked daily increased.  They also observed an interaction 
between smoking and both gender and age with respect to plasma Hcy concentration.  Female 
smokers experienced a greater effect of smoking than males, and the effect of cigarette smoking 
was greater in the older age groups than in the younger groups (Nygard et al., 1995). 
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Physical activity levels: Reports conflict on the effect of physical activity on plasma Hcy 
levels.  Nygard and colleagues (1995) reported that there was an inverse relationship between 
Hcy concentration and physical activity levels, and that Hcy levels were dependent on the 
intensity of physical activity that the participants were involved in.  A more recent investigation 
of the relationship between physical activity status (sedentary vs. light or moderate vs. vigorous 
exercise) and plasma Hcy concentration revealed no associations, though specific types of 
exercise were associated with lower Hcy levels.  Chrysohoou et al. (2004) reported that 
endurance exercise led to lower Hcy levels whereas resistance exercise had no effect in either 
men or women.  Average Hcy concentration for females in endurance training is 8.0 ± 2.1 
µmol/L, compared with 10.4 ± 1.9 µmol/L for those involved in resistance training, and 12.5 ± 
1.8 µmol/L for sedentary females (Chrysohoou et al., 2004).  No associations were found 
between the prevalence of obesity and Hcy concentration (Chrysohoou et al., 2004). 
2.1.2.5 Gender and steroid hormones 
Males tend to have higher Hcy levels than females (Chrysohoou et al., 2004), which 
could be associated with an increased risk of developing cardiovascular disease (Nygard et al., 
1998; McCarty, 2001).  Nygard and colleagues (1995) have reported an average plasma Hcy 
concentration of 10.84 µmol/L for males and 9.14 µmol/L for females, while other authors have 
reported average concentrations of 14.5 ± 6 µmol/L for males and 10.8 ± 3.5 µmol/L for females 
(Chrysohoou et al., 2004).  Increases in plasma Hcy concentration in response to age were found 
in both genders (10.84, 11.22, 12.27 µmol/L for men, 9.14, 9.89, 11.04 µmol/L for women aged 
40-42, 43-64, and 65-67 years) (Nygard et al., 1995). 
The difference in Hcy levels is likely due to concentrations of sex steroid hormones such 
as estradiol and progesterone, which are prevalent in premenopausal females, and have been 
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found to be slightly but insignificantly negatively correlated with plasma Hcy concentration 
(Tallova, Tomandl, Bicikova, & Hill, 1999).  The lack of significance of the correlation could be 
due to the small number of participants assessed. 
Further evidence in support of a relationship between steroid hormones and plasma Hcy 
concentration lies in the fluctuation of Hcy levels in response to menstrual cycle phase.  Plasma 
Hcy concentration varies according to menstrual cycle phase in premenopausal females (De Cree 
et al., 1999; Steegers-Theunissen et al., 1992; Tallova et al., 1999).  Homocysteine 
concentrations increase above normal levels during the follicular phase of the menstrual cycle, 
when concentrations of estradiol and progesterone are low, and decrease during the luteal phase 
of the menstrual cycle, when concentrations of steroid hormones are high.  Tallova and 
colleagues (1999) have reported plasma Hcy concentrations of 8.9 ± 3 µmol/L in the follicular 
phase, and 7.8 ± 2.8 µmol/L in the luteal phase.  De Cree and colleagues (1999) found plasma 
Hcy levels to be 9.44 ± 1.65 µmol/L in the follicular phase, and 8.93 ± 1.71 µmol/L in the luteal 
phase.  In each of these studies, the participants were not taking oral contraceptives, and were 
premenopausal but not pregnant.  These variations indicate that there are cyclical variations of 
Hcy during the menstrual cycle. 
Because of the known changes in Hcy concentration due to different hormone 
concentrations, similar changes should be expected with oral contraceptives.  Steegers-
Theunissen and colleagues (1992) studied the effect of sub-50 oral contraceptives on plasma Hcy 
concentration and vitamin status in premenopausal females.  While the authors also found that 
there were cyclical variations in plasma Hcy concentrations, with increased levels in the 
follicular phase when compared to the luteal phase, this result was only present in those taking 
the oral contraceptives.  Menstrual cycle phase had no impact on Hcy concentration in the 
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control group, who were not taking oral contraceptives.  Homocysteine levels in the treatment 
group were 11.0 µmol/L during the early follicular phase and 7.8 µmol/L during the early luteal 
phase, while in the control group the concentrations were 6.6 µmol/L and 6.4 µmol/L for the 
respective cycle phases.  The authors did however note that the absence of a significant 
difference between phases in the control group could have been due to the failure of four out of 
15 participants to demonstrate a decrease in Hcy.  Significant differences between groups in Hcy 
concentration during the luteal phase were not present. 
Menopausal women experience increases in plasma Hcy when compared to 
premenopausal women (12.0 ± 5.2 vs. 9.9 ± 2.9 µmol/L) (Chrysohoou et al., 2004), which 
corresponds to a decrease in steroid hormones (Refsum et al., 1998). 
2.1.2.6 Dietary composition 
Folate and vitamin B12 are both involved in the remethylation of Hcy to form methionine, 
while vitamin B6 is involved in the transsulphuration of Hcy to form cysteine in the presence of 
sufficient amounts of methionine (Refsum et al., 1998).  Because of the large role that these B 
vitamins play in Hcy metabolism, exclusion or deficiencies of folate and vitamins B6, and B12 in 
the diet can lead to impaired metabolism, which ultimately can result in increased concentration 
of Hcy in the bloodstream (Selhub, 1999). 
2.1.2.7 Folate and vitamin B6 
Folate is a necessary factor in the remethylation pathway, and therefore plays a 
significant role in resulting plasma Hcy concentrations, as the remethylation of Hcy to form 
methionine would be severely limited with deficiencies of folate (Refsum et al., 1998; Selhub, 
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1999).  The presence of folate in sufficient quantities in the diet is necessary for the smaller 
tetrahydrofolate cycle that is the source of the methyl group for Hcy remethylation. 
Folate has a significant dose-response relationship with plasma Hcy concentration 
(Nygard et al., 1998).  In this study, baseline data collected from 11,941 participants from the 
Hordaland Homocysteine Study cohort (Nygard et al., 1995) was used to determine dietary 
factors that affect total Hcy concentration (Nygard et al., 1998).  The authors reported that 
although folate is readily available in foods such as fruits and vegetables, juices, eggs and meat, 
large variations observed in plasma Hcy may be due to low folate intake and a lack of folate 
supplementation (Nygard et al., 1998).  Folate is also available in fortified grain products, 
legumes and beans (Institute of Medicine of the National Academies, 2006).  Folate scores were 
found to be higher in females than males in individuals between the ages of 40 and 42 years (1.8 
vs. 1.7 µmol/L) while the opposite was true in individuals between the ages of 64 and 67 years 
(2.4 vs. 2.7 µmol/L).  Folate status is not likely to be a confounding factor in the current study, 
due to the age and healthy status of the female participants. 
Jacques et al. (1999) investigated the effects of folic acid fortification in individuals 
participating in the Framingham Heart Study, a study of individuals with heart disease.  The 
authors reported that participants who ate fortified foods experienced a decrease in plasma Hcy 
concentration (10 %), while those supplementing with both B vitamins and folate or with B 
vitamins only showed no change.  The absence of change in the B vitamin groups could be due 
to the lower initial Hcy concentrations and higher plasma folate levels in these participants.  This 
could be due to the presence of folic acid in the B vitamins (Jacques et al., 1999).  The groups 
had significant differences in concentration of vitamins B6 and B12 initially, and so the resulting 
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change in the folate group cannot be attributed with total certainty to the folate fortification 
(Jacques et al., 1999). 
Cuskelly, Stacpoole, Williamson, Baumgartner, and Gregory (2001), investigated Hcy 
kinetics while participants were in either a folate or vitamin B6 deficient state.  Homocysteine 
concentration in the folate deficient group at the end of a six week folate depletion period was 
15.9 ± 2.1 µmol/L, and in the vitamin B6 depleted group was 7.7 ± 2.1 µmol/L compared to 7.4 ± 
1.7 µmol/L in the control group.  There were no significant differences in Hcy concentration 
between the control and vitamin B6 groups following the dietary depletion.  This indicates that 
even in a vitamin B6 depleted state, there is no significant effect on Hcy status.  While this 
vitamin plays a role in Hcy metabolism, changes in B6 will not impact Hcy in the bloodstream, 
whereas folate deficiencies result in increases of Hcy past the normal range. 
In rats, deficiencies of vitamin B6 do not seem to have as severe an impact on plasma Hcy 
concentration as deficiencies of folate (Miller, Nadeau, Smith, & Selhub, 1994).  B6 deficient 
rats did not have increased plasma Hcy concentrations when compared with controls, while 
folate deficient rats had significantly higher Hcy levels (Miller et al., 1994).  Differences in Hcy 
concentration between the B6 deficient and folate deficient groups may be due to the role played 
by each of the components in Hcy metabolism. 
Vitamin B6 does not play a role in the remethylation of Hcy to form methionine.  It is 
however a factor in the transsulphuration pathway, which occurs in the presence of excess 
methionine within the cell (Refsum et al., 1998).  Vitamin B6 is available in highly fortified 
cereals, beef liver and organ meats and fortified soy based meat substitutes (Institute of Medicine 
of the National Academies, 2006).  Vitamin B6 deficiencies generally cause only a mild 
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impairment of the transsulphuration pathway (Selhub, 1999).  This helps to prevent the 
precipitation of hyperhomocysteinemia in the presence of a fully active remethylation pathway 
and residual activity of the transsulphuration pathway when dietary methionine intake is not 
significant. 
Miller and colleagues (1992) explored vitamin B6 depletion and resulting plasma Hcy 
concentration in elderly individuals.  The participants were first tested following their normal 
diet, and then following a vitamin B6 depletion period of less than 20 days.  After the depletion 
period, the participants underwent three successive 21 day repletion periods, whereby vitamin B6 
was returned to their diets in different quantities (Period 1: 15 µg/kg body weight/day; Period 2: 
22.5 µg/kg body weight/day; Period 3: 33.75 µg/kg body weight/day).  The authors found no 
significant differences in plasma Hcy concentration in response to the B6 depletion or in response 
to the different repletion periods.  Miller and colleagues (1992) also studied the B6 depletion 
states in different age-grouped (three and 23 month old) rats and compared them to B6 replete, 
pair-fed rats, with data collections at six and nine weeks.  The authors compared the dietary 
groups, and different age groups.  Plasma Hcy concentration increased in the vitamin B6 
deficient three month old rats at nine weeks, though there were no significant differences at the 
six week testing point, or at any time point in 23 month old rats.  Vitamin B6 deficiency is 
therefore not always represented by increases in plasma Hcy concentration. 
2.1.2.8 Vitamin B12 
Elevation of Hcy concentration in plasma is often due to dietary habits such as 
vegetarianism, where there are certain factors involved in Hcy metabolism that are lacking in the 
diet.  The disruption at the cellular level is frequently caused by deficiency of nutrients required 
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in the metabolic pathway of Hcy.  These include vitamin B12 and guanidinoacetate (a precursor 
to creatine), both of which play key roles in Hcy metabolism. 
Impairment of remethylation will lead to an extensive increase in plasma Hcy 
concentration.  As a diet moves from omnivorous to a strict vegan diet, decreases in vitamin B12 
concentration progress due to decreased intake of vitamin B12 containing foods (Obeid, Geisel, 
Schorr, Hubner, & Herrmann, 2002).  Without the use of fortified foods or supplements, 
vegetarians have a limited intake of vitamin B12 (Barr & Rideout, 2004).  Plasma B12 levels are 
inversely correlated with plasma Hcy levels, which is likely due to decreases in Hcy metabolism 
as a result of deficiencies in vitamin B12 intake (Obeid et al., 2002).  Vitamin B12 concentrations 
in omnivorous populations are 403.5 ± 138.9 pmol/L, compared with 207.7 ± 127.1 pmol/L in 
vegetarians (Hung et al., 2002).  Such low values in vegetarians are likely to have a negative 
impact on cellular Hcy metabolism, subsequently causing increases in plasma Hcy 
concentrations. 
Oral supplementation with vitamin B12 is associated with decreased levels of plasma Hcy, 
though decreases are of a relatively small magnitude (10-15 %) when compared to individuals 
with folate deficiencies (25-50 %) (Refsum et al., 1998).  Recent attempts at decreasing plasma 
Hcy concentrations using a combination of folate and vitamins B6, B12 have found that while 
supplementation decreased Hcy concentration, the risk of a cardiovascular event increased 
among patients with baseline plasma Hcy levels greater than 13 µmol/L (Bonaa et al., 2006).  
Important to note is that the population for this research was chosen based on the occurrence of 
an acute myocardial infarction within seven days previous to randomization into the intervention 
groups.  Similarly, Lonn and colleagues (2006) based their participant selection on the presence 
of a history of vascular disease, and did not attempt to determine the effects of supplementation 
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on a healthy population with increased plasma Hcy concentration.  Lonn and colleagues (2006) 
found that supplementation with different amounts of the same vitamins combined did not 
prevent the recurrence of cardiovascular events, though plasma Hcy concentration was 
decreased.  Vitamin B6 was suggested to have adverse effects on vascular modeling and 
myocardial repair (Bonaa et al., 2006).  However, since both vitamin B6 and folate are readily 
available in a variety of foods, as mentioned previously, supplementation of the diet with this 
combination of vitamins is often unnecessary.  Individuals with normal plasma folate 
concentrations, but with vitamin B12 deficiencies, such as vegetarians, could benefit from 
vitamin B12 supplementation.  It is possible that a decrease ranging between 10 and 15 % of their 
initial plasma Hcy concentration would place vegetarians in the normal Hcy range. 
Vitamin B12 is mainly found in meats, eggs and milk, and therefore may be absent or 
available in limited quantities in a lacto-ovo or vegan diet.  Folate and vitamins B2 and B6 are 
also found in animal products, but are also prevalent in a number of plant foods and nuts (Obeid 
et al., 2002).  Folate utilization might be compromised in times of depleted vitamin B12 
concentration, due to the inability of the cell to produce sufficient amounts of tetrahydrofolate, 
and this could decrease Hcy metabolism (Obeid et al., 2002).  Without proper amounts of 
nutrients such as those found in animal products, specifically meat products, Hcy metabolism 
may be limited, resulting in increases in Hcy being released into the bloodstream. 
2.1.2.9 Vegetarian diets and homocysteine levels 
Vegetarians have higher concentrations of plasma Hcy when compared to non-
vegetarians, with the extent of vegetarianism (i.e. lacto-ovo vegetarian vs. vegan) playing a 
modulating role (Bissoli et al., 2002; Herrmann, Schorr, Purschwitz, Rassoul, & Richter, 2001; 
Hung et al., 2002; Krajcovicova-Kudlackova, Blazicek, Kopcova, Bederova, & Babinska, 2000; 
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Obeid et al., 2002).  Lacto-ovo vegetarians (does not consume meat, chicken, or fish, but may 
include dairy products and eggs within their diets (Herrmann et al., 2001)) have increased plasma 
Hcy levels when compared to non-vegetarians (Bissoli et al., 2002; Herrmann et al., 2001; Hung 
et al., 2002; Krajcovicova-Kudlackova et al., 2000; Obeid et al., 2002), and vegans (do not 
include animal or dairy products in their diets) experience even greater increases in plasma Hcy 
(Herrmann et al., 2001; Krajcovicova-Kudlackova et al., 2000; Obeid et al., 2002). 
Homocysteine concentrations vary between 10.5 and 17.4 µmol/L in lacto-ovo 
vegetarians, and between 8.6 and 11.6 µmol/L in non-vegetarians (Bissoli et al., 2002; Herrmann 
et al., 2001; Hung et al., 2002; Krajcovicova-Kudlackova et al., 2000; Obeid et al., 2002).  
Vegans have even higher plasma Hcy concentrations than lacto-ovo vegetarians or non-
vegetarians.  Plasma Hcy concentrations in vegans range from 12.8 to 26.9 µmol/L (Bissoli et 
al., 2002; Herrmann et al., 2001; Krajcovicova-Kudlackova et al., 2000; Obeid et al., 2002).  
Though it would seem that individuals adhering to a vegan diet would be at a higher risk for 
increased plasma Hcy concentration, a lacto-ovo vegetarian diet also seems to result in higher 
than normal concentrations.  Due to the association between Hcy and cardiovascular disease, it is 
of interest to determine ways to decrease plasma Hcy levels. 
Elevated concentrations of Hcy are likely due to nutritional deficiencies that are 
associated with a vegetarian diet, specifically deficiencies in vitamin B12.  With regard to plasma 
folate concentration, lacto-ovo vegetarians and vegans have been found to have similar or greater 
levels when compared to omnivores (Bissoli et al., 2002; Herrmann et al., 2001; Hung et al., 
2002; Krajcovicova-Kudlackova et al., 2000; Obeid et al., 2002).  Therefore, folate deficiencies 
and therefore limitations with regard to the participation of folate in Hcy metabolism in these 
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groups were not anticipated.  Similarities in this nutritional component are likely due to 
increased intake of folate-containing plant foods or nuts ingested by vegetarians and vegans.
  
2
3
 
Table 2.1. Summary of studies that have investigated homocysteine concentration in different dietary groups. 
Abbreviations: high meat eater (HME), homocysteine (Hcy), lacto-ovo vegetarian (LOV), low meat eater (LME), non-
vegetarians (NV), vegetarians (pooled) (VG), vegan (VE), (male/female). 
Reference Participants Comparisons Hcy concentration 
(µmol/L) 
Results 
Bissoli et al., 2002 31 VE (19/12); age 45.8 ± 15.8 
14 LOV (6/8); age 48.5 ± 14.5 
29 NV (19/10); age 43.8 ± 17.3 
VG vs. NV 
VG with vitamin B6 + B12 
supplements (n = 9) vs. VG 
without 
VE vs. LOV 
VEG: 26.9 ± 24.1 
LOV: 17.4 ± 11.1 
VG: 23.9 ± 21.3 
NV: 11.6 ± 4.9 
VG > NV 
VG with supplements 
< VG without 
 
Herrmann et al., 
2001 
44 HME (14/30); age 23 
29 LME (2/17); age 24 
34 LOV (10/24); age 22 
7 VE (2/5); age 22 
VG, VE, LOV, LME vs. 
HME 
HME: 9.8 (median) 
LME: 11.8 
LOV: 11.0 
VE: 15.2 
VG: 11.6 
LME > HME 
LOV > HME 
VE > HME 
VG > HME 
 
Hung et al., 2001 Healthy females, age 31-45 
45 VG; 45 NV  
VG vs. NV VG: 11.20 ± 4.27 
NV: 8.64 ± 2.06 
VG > NV 
Krajicovicova-
Kudlackova et al., 
2000 
32 VE (10/22); age 41.5 ± 1.8 
62 LOV (24/38); age 35.1 ± 0.9 
59 NV (22/37); age 40.9 ± 0.7 
VG vs. NV VE: 15.79 ± 0.85 
LOV: 13.18 ± 0.26 
NV: 10.19 ± 0.29 
VG > NV 
Obeid et al., 2002 Healthy individuals, age 46 ± 
15 
29 VE (13/16); age  
64 LOV (28/36); age  
20 LME (8/12); age  
VE vs. LME 
VE vs. LOV 
LOV vs. LME 
VE: 12.8 (median) 
LOV: 10.5 
LME: 8.7 
VE > LME 
VE vs. LOV: p = 0.05 
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2.1.3 Creatine 
Creatine is a compound found in animal products - specifically meats - though in the 
human body it is also produced endogenously from amino acids in the liver, pancreas and 
kidneys (Greenhaff et al., 1994; Kraemer & Volek, 1999).  In humans, creatine is present 
primarily in skeletal muscle, with lesser concentrations also found in cardiac and smooth muscle, 
brain, kidney and spermatozoa (Harris et al., 1992).  Creatine, in both the free and 
phosphorylated form, plays a key role in muscle energy metabolism (Greenhaff et al., 1994).  
Skeletal muscle force production is dependent on the availability of phosphocreatine.  Through 
the reversible creatine kinase reaction, creatine is phosphorylated to form phosphocreatine 
(Meyer, Sweeney, & Kushmerick, 1984), providing an energy store at a number of sites, mainly 
within the cytoplasm, but also in the mitochondrial matrix of muscle cells (Houston, 2001).  In 
the reverse reaction, phosphocreatine donates or transfers a phosphate to ADP to produce ATP 
and creatine (Meyer et al., 1984).  Phosphocreatine therefore plays a central role in the 
maintenance of ATP homeostasis via the creatine kinase reaction by providing the cell with 
energy in times of increased ATP hydrolysis (Harris et al., 1992). 
2.1.3.1 Supplementation protocols 
In the past, a number of researchers have set out to determine the best way to maximize 
the uptake of creatine into muscle via oral supplementation.  Originally, supplementation 
protocols called for the ingestion of 20 grams of creatine a day for a period of five days, divided 
into four daily servings, in order to “load” muscle cells (Greenhaff et al., 1994; Harris et al., 
1992).  Greenhaff and colleagues (1994) found that following the creatine loading period, muscle 
creatine concentration increased by 15 %, and others reported gains of more than 20 % (Harris et 
al., 1992).  More recently, researchers have been supplementing participants with 0.3 grams of 
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creatine per kilogram of body mass during the loading phase of supplementation (Syrotuik & 
Bell, 2004).  Also, supplementing with 0.25 grams of creatine per kilogram of lean tissue mass 
has been described as the best way to maximally increase creatine uptake while minimizing 
excretion of creatine in urine (Burke, Smith-Palmer, Holt, Head, & Chilibeck, 2001).  
Additionally, research that has evaluated optimal solutions in which to consume creatine has 
found that carbohydrate solutions are more effective at maximizing whole body creatine 
retention than ingestion of creatine mixed with water (Green, Simpson, Littlewood, MacDonald, 
& Greenhaff, 1996). 
2.1.3.2 Creatine responders and non-responders 
There are responders and non-responders to creatine supplementation (Greenhaff et al., 
1994; Harris et al., 1992; Syrotuik & Bell, 2004).  In response to the 20 grams per day protocol, 
Greenhaff and colleagues (1994) classified responders as those who had lower initial 
concentrations of muscle creatine, and who demonstrated a significant increase in total creatine 
and an accelerated rate of phosphocreatine resynthesis in the second minute of recovery from 
intense muscular contraction after supplementation, while non-responders had higher initial 
concentrations and experienced smaller increases and rate of phosphocreatine resynthesis.  Harris 
and colleagues (1992) also found that increases in total creatine as a result of oral 
supplementation appeared to be dependent on initial total creatine content, and that those with 
the lowest initial content showed the greatest increase.  It was also noted that 20 to 40 % of the 
increase in total creatine content was accounted for by an increase in phosphocreatine. 
Syrotuik and Bell (2004) defined responders as those whose muscle total creatine 
concentration (creatine and phosphocreatine) increased by 20 mmol/kg dry weight, and non 
responders as those who did not demonstrate an increase of more than 10 mmol/kg dry weight.  
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The authors also described a third group of individuals who fell between responders and non-
responders, the quasi responders.  Once again, responders were found to have initial total 
creatine contents that were lower than the mean (111.12 mmol/kg dry weight) and showed the 
greatest increases when supplemented with creatine monohydrate. 
2.1.4 Creatine and exercise performance 
Supplementation with creatine monohydrate increases the total body creatine pool 
(Greenhaff et al., 1994), which therefore can increase the production of phosphocreatine via the 
creatine kinase reaction (Hultman, Soderlund, Timmons, Cederblad, & Greenhaff, 1996).  
Creatine supplementation influences muscle metabolism by increasing phosphocreatine levels 
which allows the resynthesis of ATP during anaerobic exercise (Kraemer & Volek, 1999).  
Phosphocreatine donates or transfers a phosphate to ADP in the production of ATP to be used in 
muscle contraction (Meyer et al., 1984).  During maximal, short term exercise the store of ATP 
in skeletal muscle can be depleted within one to two seconds.  Therefore a dependency exists for 
the conversion of ADP to ATP very rapidly, which allows maximal efforts to continue for 
approximately 30 seconds more (Casey & Greenhaff, 2000). 
Suggestions have been made that in order to see an improvement in performance with 
creatine supplementation, muscle total creatine must increase by at least 20 mmol/kg dry weight 
(Syrotuik & Bell, 2004).  A number of studies have found that oral creatine supplementation has 
an effect on maximal exercise. 
2.1.4.1 Resistance or strength training 
When coupled with resistance training, creatine supplementation results in increases in 
cross sectional area of type I, IIa and IIab muscle fibres (Volek et al., 1997).  This increase 
 27 
 
translates into improvements in force production when participating in high-intensity, short 
duration activities, such as resistance or strength training (Volek & Rawson, 2004).  Few 
researchers have focused their efforts on the effects of creatine supplementation on strength in 
females or vegetarians. 
Brenner , Rankin and Sebolt (2000) investigated the effect of six weeks of creatine 
supplementation (20 g Cr/day for seven days; 2 g Cr/day for five weeks) coupled with resistance 
training on strength measures in female collegiate lacrosse athletes.  Creatine supplementation 
resulted in an increase in one repetition maximum (1RM) performance in the creatine group 
when compared to those supplementing with placebo. 
Vandenberghe and colleagues (1997) investigated the effects of a 10 week creatine 
supplementation protocol (4 days of 20 g/day loading, followed by 10 weeks of 2.5 g/day 
maintenance supplementation) in university aged sedentary females.  During the maintenance 
period, participants began a resistance training program that included one hour of activity three 
times each week.  The participants then continued supplementing (2.5 g/day) for an additional 10 
weeks without resistance training.  The researchers measured the participants‟ 1RM for leg press, 
bench press, leg curl, leg extension, squat, and shoulder press before and after five and ten weeks 
of training, as well as arm flexion torque before and after four days, five and ten weeks of 
creatine loading.  For the measurement of arm flexion torque, the participants completed five sets 
of 30 dynamic maximal voluntary contractions separated by two minute rest intervals.  At ten 
weeks, the creatine group had significantly greater performances in 1RM tests for leg press, leg 
extension, and squat when compared to placebo, and also had non-significant increases in bench 
press and leg curl performances.  No significant differences in arm flexion torque between 
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groups following the four day loading period were found, though at both five and ten weeks the 
creatine group had greater scores. 
Ferguson and Syrotuik (2006) supplemented resistance trained females with creatine for a 
period of ten weeks (0.3g Cr/kg body mass for seven days; 0.03 g Cr/kg body mass for nine 
weeks).  During this intervention, the females participated in a resistance training program for 
four days each week.  Increases in strength as assessed by 1RM bench press and incline leg press 
were found at the end of the ten week period in both the creatine and placebo groups.  The 
authors suggested that the similarities between groups may be due to the presence of non-
responders within their subject pool.  Burke and colleagues (2003) investigated the effect of 
creatine supplementation (0.25 g Cr/kg lean tissue mass for seven days; 0.0625 g Cr/kg for seven 
weeks) on exercise performance in vegetarians and non-vegetarians.  The authors assessed the 
participants‟ performance on 1RM bench and leg press tests, as measures of strength before and 
after supplementation coupled with an eight week resistance training program.  A significant 
supplement by time interaction for 1RM bench press was revealed by the statistical analysis, 
whereby those participants supplementing with creatine experienced a greater increase in bench 
press when compared to the placebo group. 
2.1.4.2 Anaerobic capacity 
Supplementation with creatine monohydrate increases total muscle creatine and 
phosphocreatine concentration, which may allow for improvements in short duration, high 
intensity activity (Williams & Branch, 1998).  Anaerobic capacity is directly related to 
concentrations of ATP, and by increasing the amount of phosphocreatine available in the muscle, 
dependence on anaerobic glycolysis is reduced, potentially allowing the muscle to work for 
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longer periods of time.  Very few researchers have focused on the effects of creatine 
supplementation on anaerobic capacity specifically in females or vegetarians. 
Thompson and colleagues (1996) had female competitive swimmers supplement for 56 
days (2 g Cr/day), and measured performance on a 100 meter swim.  Supplementation had no 
effect on concentrations of phosphocreatine or ADP in the muscle, and did not improve swim 
performance when compared to placebo.  It is likely that the supplementation protocol used in 
this situation was too low to cause a difference in muscle metabolites and performance. 
Cox, Mujika, Tumilty and Burke (2002) supplemented elite female soccer players with 
creatine monohydrate for a period of six days (20 g Cr/day), while training with simulated match 
play.  Those supplementing with creatine decreased their sprint times at various points in the 
simulated match, though the final effect was not statistically different.  Creatine supplementation 
also resulted in decreases during various agility run times throughout the match, though once 
again the total time did not significantly decrease.  The authors suggest that in spite of there 
being no overall significant differences when looking at sprint times, in a soccer match, having 
one or two sprints that are improved could help to change the result of the game, and that 
therefore supplementation with creatine is worthwhile. 
2.1.4.3 Aerobic capacity 
Because aerobic exercise is characterized by cellular respiration and does not depend 
primarily on the production of ATP from phosphocreatine and ADP, creatine supplementation is 
thought to have minimal effect on aerobic performance.  However, it is important to recognize 
that creatine supplementation could potentially affect the phosphocreatine shuttle, which acts as 
an intracellular system for the transfer of high energy phosphates (Kammermeier, 1986; Meyer et 
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al., 1984).  Specifically, this shuttle allows the transfer of energy between the mitochondrion and 
cytoplasm of muscle fibres (Kammermeier, 1986).  Free creatine in the cytoplasm of muscle 
fibres moves into the mitochondrion, where it has been found to accept a phosphate from ATP 
stores, thus regenerating phosphocreatine (Bessman & Carpenter, 1985).  The newly formed 
phosphocreatine then returns to the cytoplasm of the contracting fibre, and allows for the 
reformation of ATP and the availability of free creatine once again, which returns to the 
mitochondrion to repeat the cycle.  Enhanced levels of creatine, as would occur through 
supplementation may enable greater mitochondrial ATP availability and subsequently enhance 
aerobic performance. 
It is of note however, that research based on this premise has failed to find a significant effect of 
creatine supplementation on aerobic performance (Chwalbinska-Moneta, 2003), heart rate 
response or blood lactate response to aerobic exercise (Vanakoski, Kosunen, Meririnne, & 
Seppala, 1998), or total work performed and/or average power output during the last 15 minutes 
of a 28 minute submaximal endurance (Reardon, Ruell, Fiatarone Singh, Thompson, & Rooney, 
2006). 
2.1.5 Vegetarians and creatine supplementation 
Due to the lack of animal products in their diets, vegetarians generally have lower 
baseline levels of total creatine than individuals adhering to a non-vegetarian diet.  Dietary 
creatine intake accounts for approximately 50 % of the body‟s daily need for creatine (Syrotuik 
& Bell, 2004).  However, in spite of their creatine depleted diet, biopsied muscle samples from 
vegetarians had normal total creatine content (n = 2; 120.0 and 114.6 mmol/kg dry mass) (Harris 
et al., 1992).  Conversely, a study examining the impact of a lacto-ovo vegetarian diet for 21 
days found a significant decrease in total muscle creatine (n = 12; mean ± SE: 126.0 ± 2.4 vs. 
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113.9 ± 3.9 mmol/kg dry mass) (Lukaszuk et al., 2002).  A sample of the participants (n = 6) 
were then supplemented with creatine monohydrate for a period of five days (0.3 g Cr/kg body 
mass), and the total creatine stores increased to levels greater than when following an 
omnivorous diet (n = 7) (148.6 ±4.5 vs. 141.7 ± 4.5 mmol/kg dry mass), suggesting that there is a 
potential to increase total muscle creatine stores in both vegetarians and non-vegetarians.  A 
reasonable assumption to make would be that these increases in total muscle creatine stores 
should allow for improvements in performance on anaerobic fitness and strength measures.
  
 
3
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Table 2.2. Summary of studies that have examined the effect of creatine supplementation on fitness in vegetarians. 
Abbreviations: baseline (BL), creatine (Cr), muscle creatine concentration ([Cr]), day (d), gram (g), kilogram (kg), lean 
tissue mass (LTM), non-significant (n.s.), non-vegetarian (NV), muscle phosphocreatine concentration ([PCr]), placebo 
(Pl), resistance training (RT), standard error (SE), total muscle creatine concentration ([tCr]), urinary (UR), vegetarian 
(VG), (male/female), change in (Δ). 
Reference Participants Treatment Testing Response 
Burke et al., 2003 18 VG 
24 NV 
Cr: 7d, 0.25 gCr/kgLTM/d; 49d, 
0.0635 gCr/kgLTM/d, plus RT. 
VGCr (n = 10) (5/5); age 31 ± 2.2 
VGPl (n = 8) (3/5); age 34 ± 4.2 
NVCr (n = 12) (7/5); age 33 ± 2.6 
NVPl (n = 12) (5/7); age 32 ± 2.4 
Comparisons of LTM, 
[tCr], urinary Cr 
output, 1RM bench 
and leg press, 50 leg 
extensions, training 
volume 
Δ LTM: CrVG > CrNV, Cr > Pl 
[tCr]: NV > VG 
UR Cr (BL): NV > VG 
Δ 1RM bench press: Cr > Pl 
Δ 1RM leg press: n.s. 
Leg extensions: CrNV > CrVG, Pl 
Training volume: Cr > Pl 
Lukaszuk et al., 
2005 
26 NV 
- 12 VG diet; 
age 24.1 ± 1.4 
- 14 NV diet; 
age 22.9 ± 0.6 
21d of dietary treatment, 5d Cr/Pl 
treatment (0.3 gCr/kgLTM/d) 
VGPl 
VGCr 
NVPl 
NVCr  
[tCr] 
[PCr] 
[Cr] 
Cr > Pl in VG and NV for [tCr],  
[PCr], and [Cr] 
Shomrat et al., 
2000 
Healthy males 
7 VG 
17 NV 
Cr: 3 x 7g/day for six days 
NVPl; age 27.4 ± 1.9 (SE) 
NVCr; age 26.1 ± 0.6 
VGCr; 29.6 ± 2.7 
Plasma Cr 
3 Wingate repetitions 
BL Plasma Cr: VG < NV 
Plasma Cr: ↑ with Cr 
Mean Power: ↑ with Cr 
Peak Power: ↑ in NV 
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2.1.6 Creatine and homocysteine metabolism 
Creatine is synthesized endogenously in the human body via the methylation of 
guanidinoacetate by guanidinoacetate-methyl transferase with SAM donating the methyl group 
(Taes et al., 2004).  This methylation of guanidinoacetate accounts for 70 % of transmethylation 
reactions in the body (Taes et al., 2004).  Creatine supplementation may therefore play a role in 
the regulation of plasma Hcy levels (Wyss & Schulze, 2002), in that by downregulating the 
endogenous need for creatine, there would be less need for these transmethylation reactions, 
thereby decreasing Hcy concentration (Taes et al., 2004). 
In the presence of exogenous creatine, such as is supplied by supplementation, the 
methylation of guanidinoacetate to form creatine may decrease, since the end product of this 
methylation is creatine.  With an excess of creatine, the need for endogenous creatine would be 
decreased, which would theoretically decrease the prevalence of the reaction.  Though 
guanidinoacetate is only one of the many methyl acceptors that can take part in the remethylation 
pathway, supplementation with creatine could result in a decrease in methyl donation by SAM.  
This ultimately would cause a decline in the amount of SAH produced in response to SAM being 
spared, and subsequently lessen the regeneration of Hcy within the cell (Wyss & Schulze, 2002). 
Reports on the effects of creatine supplementation on plasma Hcy levels have been 
contradictory (Korzun, 2004; Stead et al., 2001; Steenge et al., 2001; Taes, 2005; Taes et al., 
2004; Taes et al., 2003).  A study comprised of chronic hemodialysis patients who supplemented 
with creatine reported no decrease in total plasma Hcy concentration (Taes et al., 2004).  These 
participants ingested two grams of creatine each day, an amount that is not the standard for 
creatine supplementation, and therefore may not have resulted in optimal creatine uptake.  In 
 34 
 
contrast, Korzun (2004) found that creatine supplementation decreased plasma Hcy 
concentration in seven out of eight individuals supplementing with creatine.  Four of the 
individuals supplementing showed decreases between 18 % and 27 %.  Stead et al. (2001) 
reported a 27% decrease in plasma Hcy concentration in response to oral creatine 
supplementation (0.4 % wt/wt creatine) in male rats.  Taes and colleagues (2003) reported 
decreases in plasma Hcy in nephrectomized male rats following creatine supplementation (2 % 
wt/wt creatine monohydrate), when compared to control fed animals.  They also found that 
plasma Hcy concentration decreased following creatine supplementation when comparing pooled 
data of nephrectomized and sham operated animals supplementing with creatine to those 
supplementing with placebo (Taes et al., 2003). 
Creatine supplementation and resistance training in non-vegetarians has no significant 
effect on plasma Hcy levels (Steenge et al., 2001).  Including non-vegetarians in the sample may 
have decreased the possibility of a significant effect, as non-vegetarians‟ diets would likely 
already contain optimal doses of creatine.  The participants included in this study did not have 
elevated serum Hcy levels initially, and therefore may not have experienced decreases as might 
be expected in individuals with elevated concentrations, such as vegetarians sometimes have. 
It is apparent from these mixed results that the impact of creatine supplementation on 
plasma Hcy concentration is dependent on a variety of factors, including baseline Hcy 
concentration and dietary status.  In spite of these mixed results, optimal creatine 
supplementation techniques in individuals with low dietary intake of creatine and higher Hcy 
concentration in plasma, as is the case with a vegetarian diet, could decrease plasma Hcy 
concentration.
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Table 2.3. Summary of studies that have examined the effect of creatine supplementation on homocysteine concentration. 
Abbreviations: baseline (BL), creatine (Cr), day (d), gram (g), homocysteine (Hcy), milligram (mg), multivitamins (MV), 
placebo (Pl), resistance training (RT), weight (wt), (males/females), change in (Δ) 
Reference Population/Participants Supplementation Hcy concentration (µmol/L) Results 
Korzun, 2004 Healthy males and 
females; n = 16 
Cr: 28d of 2.1-5.5 g/d 
MV (B6 + B12) (3/5); age 
31 ± 13 
MV + Cr (4/4); age 29 ± 8 
MV BL: 6.2 ± 1.2 
MV Δ: + 0.2 ± 0.5 
MV + Cr BL: 7.1 ± 1.8 
MV + Cr Δ: - 0.9 ± 0.7 
Hcy ↓ in MV + Cr 
- 4 participants 
decreased 18 – 27 % 
Stead et al., 2001 Healthy male Sprague 
Dawley rats 
Cr: 14d of 0.4 % wt/wt 
Control 
↓ 27 % in Cr fed rats Hcy ↓ in response to Cr 
Steenge et al., 
2001 
Healthy women; age 19 – 
38 
Cr: 5d of 20 g/d, 46d of 3 
g/d 
Cr (n = 7) 
Cr + RT (n = 8) 
Pl (n = 5) 
Cr Δ: - 0.3 ± 0.5 
Cr + RT Δ: - 0.6 ± 0.5 
Pl Δ: - 0.6 ± 0.5 
No differences were 
found with Cr 
Taes et al., 2004 Chronic hemodialysis 
patients, supplementing 
with 5 mg folic acid, 50 
mg pyroxene (B6), 12 µg 
B12 
Cr: 2 g/d 
Cr (n = 25) (14/11); age 
71 ± 8 
Pl (n = 20) (10/10); age 69 
± 12 
BL Hcy (males): 23.3 ± 3.7; 
(females): 18.7 ± 6.1 
No differences were 
found with Cr 
Taes et al., 2003 Male Wistar rats with 
uremia 
Cr: 2 % wt/wt 
Sham operated Pl (n = 8) 
Sham operated Cr (n = 8) 
Subtotal nephrectomized 
Pl (n = 10) 
Subtotal nephrectomized 
Cr (n = 10) 
Crpost: 12.4 ± 2.2 
Plpost: 14.6 ± 1.9 
↓ Hcy in Cr vs. Pl 
Trend towards ↓ Hcy in 
sham operated Cr 
Subtotal nephrectomized 
Pl > sham operated Pl, 
subtotal nephrectomized 
Cr 
 
 36 
 
2.2 Statement of the problem 
While it has been established that males have increased concentrations of Hcy in the 
bloodstream when compared to females (Chrysohoou et al., 2004), female vegetarians could 
have elevated levels of serum Hcy when compared with non-vegetarians, due to less exogenous 
creatine availability and lower vitamin B12 intake (Bissoli et al., 2002).  Vegetarians could 
therefore be at an equal or greater risk for cardiovascular complications.  For that reason, it is 
essential to determine possible mechanisms to decrease the concentration of Hcy in the 
bloodstream in this population.  As such, the primary purpose of this research was to determine 
the effects of creatine supplementation, taken concurrently with vitamin B12 supplements, on 
serum Hcy levels in vegetarian and non-vegetarian females. 
A secondary purpose was to determine the effects, if any, of oral creatine 
supplementation on muscle strength, power and anaerobic capacity in female vegetarians and 
non-vegetarians.  The role of creatine in fitness for males has been established and reported in 
detail.  However, few studies have investigated the effect of creatine supplementation on fitness 
measures in females (Ayoama, Hiruma, & Sasaki, 2003; Cox et al., 2002), and even fewer 
focusing on those females adhering to a vegetarian diet (Burke et al., 2003). 
2.3 Hypotheses 
We hypothesized that the plasma Hcy concentration would be higher in vegetarian 
participants when compared to non-vegetarian participants, and thus hypothesized that the Hcy 
concentration of vegetarians would decrease in response to supplementation with creatine 
monohydrate.  Also, we hypothesized that the vegetarian group would experience a greater 
decrease in Hcy due to the greater baseline concentration. 
 37 
 
Additionally, we were interested in determining whether physiological performance was 
affected by the supplementation protocol, and if differences in performance were influenced by 
diet.  We hypothesized that both groups would experience improvements in physiological 
performance, including anaerobic power, fatigue and strength, in response to the creatine 
supplementation.  We also hypothesized that vegetarian participants would experience a greater 
improvement, due to lower baseline concentration of creatine. 
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3. METHODS 
3.1 Participant selection and characteristics 
3.1.1 Participants and exclusion criteria 
Participant selection was based on the availability of volunteers.  The objective of 
recruitment was to engage forty participants in total (twenty for each dietary group) in the study, 
to achieve 80 % power.  Volunteers were recruited from the Saskatoon area based on gender, 
age, and dietary classification.  Recruitment posters were put up in various fitness apparel and 
grocery stores in Saskatoon, as well as in local yoga studios, and University of Saskatchewan 
bulletin boards.  Participants were also recruited from the University of Saskatchewan 
Vegetarian Society, through newsletters and announcements, and using an advertisement in the 
Saskatoon Sun, a weekly newspaper. 
Individuals taking medication other than oral contraceptives or vitamins were excluded, 
whereas those supplementing with vitamins were asked to continue taking them regularly 
throughout the study period.  Participants between 18 and 40 years of age were recruited.  
Participants were also excluded if they had started or finished taking oral contraceptives within 
the past year, in order to avoid any hormonal fluctuations (see section 3.1.2 for rationale).  All 
participants recognized themselves as healthy individuals who participated in regular recreational 
physical activity. 
Nygard and colleagues (1995) stated that plasma Hcy progressively increases with age, 
and plasma Hcy concentration increases following menopause, which is likely due to a decrease 
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in the hormones associated with menstruation (Refsum et al., 1998).  Therefore, only those with 
regular menstrual cycles were included in the study.  Smokers also tend to have increased plasma 
Hcy levels (Chrysohoou et al., 2004; Nygard et al., 1995), and therefore were excluded from the 
study.  Participants volunteering to take part in the study met a number of criteria, as described in 
the following paragraphs. 
Participants had not supplemented with creatine for a period of three months prior to the 
study in order to ensure the absence of any residual effects in plasma and therefore minimal 
effects on plasma or serum Hcy concentration (Steegers-Theunissen et al., 1992).  Participants 
were asked to maintain their current eating habits, diet, and activity level for the duration of the 
treatment, so as to limit any confounding factors. 
The final participant sample included nine non-smoking female vegetarians (lacto-ovo 
vegetarians) and eleven non-smoking non vegetarians between the ages of 18 and 40 years.  
Ethical approval was given by the University of Saskatchewan Biomedical Research Ethics Board 
(refer to Appendix I).  All participants were made aware of the testing procedures and risks 
associated with the protocols and were asked for their informed written consent to participate in 
the study (refer to Appendix II).  They also were informed that they could withdraw from the 
study at any time without consequence. 
3.1.2 Menstrual status and oral contraceptives 
Oral contraceptives are associated with increased levels of plasma Hcy during the 
follicular phase of the menstrual cycle, while there are no differences in the luteal phase 
(Steegers-Theunissen et al., 1992).  This indicates that participants taking oral contraceptives 
may have heightened baseline serum Hcy concentration.  All participants were taking oral 
contraceptives for one year or longer, or not at all, in order to standardize testing protocols, as 
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measurements were carried out at particular times within each participant‟s menstrual cycle.  
Including this as a control allowed us to eliminate hormone fluctuations as a potential variable 
influencing Hcy concentration, body mass or composition.  Because there were no changes in 
contraceptive status, the magnitude of Hcy response to creatine supplementation should not have 
been different than those participants who do not take oral contraceptives.  Participants began the 
treatment in the early follicular phase in order to ensure the greatest baseline mean Hcy 
concentration so that a response to creatine supplementation would be more obvious. 
3.2 Experimental design 
At the onset of the study, participants were given an appointment listing detailing each of 
the upcoming five laboratory visits (refer to Appendix III).  The first appointment fell on day two 
of the participants‟ menstrual cycles.  During this meeting, participants were given vitamin B12 
supplements to take daily for the duration of the study, and completed a maximal effort aerobic 
fitness test.  Participants had their body mass, percentage body fat measurements, and total work 
performed during leg extensions measured during appointment two.  Body mass and percentage 
body fat measurements were carried out in order to determine the appropriate amount of creatine 
for supplementation.  Participants were also given three day food diaries, urine collection 
containers and instructions to complete before the next meeting.  Appointment two occurred on 
approximately day 24 of the menstrual cycle.  Day two of the following cycle marked the third 
appointment, during which participants were given creatine monohydrate to consume for the 
next five days.  Blood samples were taken, followed by strength and anaerobic fitness tests.  
During this appointment, participants also handed in their urine samples collected during the 
prior 24 hours.  Participants supplemented with creatine for five days, then returned for follow 
up blood work, mass and body fat measurements, and measurement of work performed during 
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leg extensions.  At this time, they were given new urine collection containers, and were 
instructed to collect for the next 24 hours.  The final meeting took place on approximately day 
twelve (11.5 ± 2.4) of the menstrual cycle, and included follow up measurements of strength and 
anaerobic fitness.  A visual representation of the participant timeline is given in Figure 2. 
 
Figure 2.  Graphical representation of participant timeline. 
3.2.1 Dietary intake 
Participants completed a three day food diary, including all products ingested prior to the 
study intervention (refer to Appendix IV).  Participants were asked to complete the diaries as 
accurately as possible, and to include two week days and one weekend day.  Diaries were 
analyzed using NutriBase 50-Node Network Edition, v. 6.21 (CyberSoft, Inc., Phoenix, AZ), 
which allows for the quantification of vitamin B2, B6, B12 and folate ingested in the diet, as well 
as the identification of products fortified with folate.  Energy, protein, carbohydrate, fat and 
cholesterol intake were also included in the analysis.  Creatine intake was calculated from the 
food diaries based on the creatine content of foods (milk: 0.1 g/kg; beef: 4.5 g/kg; pork: 5 g/kg; 
salmon: 4.5 g/kg) (Balsom, Soderlund & Ekblom, 1994). 
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3.2.2 Supplementation 
3.2.2.1 Vitamin B12 
Participants were supplied with unopened bottles of vitamin B12 (cyanocobalamin) tablets 
(25 µg, Jamieson Natural Sources, Toronto, ON) and were asked to begin taking the supplements 
on day two of their menstrual cycle preceding the supplementation period.  This helped to ensure 
that time did not play a role in any effect of the vitamin on serum Hcy concentration, and to 
ensure that each participant was satisfying the dietary requirements in terms of vitamin B12 
intake.  This concentration was used in order to surpass the recommended dietary allowance for 
this population of vitamin B12 (2.4 µg) (Institute of Medicine of the National Academies, 2006), 
thereby ensuring that each participant was meeting the minimum daily requirements, but also 
because most of the greater concentrations contain additives, such as calcium, which were not 
tested within this study, and could be considered confounding factors.  The dose chosen was the 
smallest possible dose of the vitamin available commercially.  The participants were instructed to 
ingest one vitamin supplement each day with a meal, as per the supplement instructions. 
3.2.2.2 Creatine 
Participants were supplied with pre-measured daily amounts of creatine monohydrate 
(Dymatize, Peak Performance Products, Toronto, ON), based on their lean body mass (LBM) as 
determined by air displacement plethysmography using a BodPod (Life Measurement, Inc., 
Concord, CA) one week prior to the supplementation period.  The sum of four skinfolds (triceps, 
biceps, subscapular and iliac crest) (Durnin & Womersley, 1974) were used to determine LBM 
for the remaining participants, because of technical problems with the BodPod.  All supplements 
were mixed with a carbohydrate containing powdered juice mix, and mixed with 250 mL of 
water by the participant.  This protocol of ingesting creatine with carbohydrate maximizes the 
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amount of creatine retained by the body (Green et al., 1996).  A five day creatine loading period 
was used.  Participants ingested 0.25 grams of creatine per kilogram of LBM (Burke et al., 
2003), separated into four equal portions and taken at four hour intervals each day (Hultman et 
al., 1996).  Seven vegetarian and six non-vegetarian participants were measured using the 
BodPod prior to the intervention, as well as following.  The remaining participants had either a 
mix of methods, or were measured using solely skinfolds, and were therefore not included in the 
statistical analysis of percentage body fat. 
3.2.3 Body mass and percentage fat 
Body mass and percentage fat were determined at the onset of the study as well as 
following the intervention in order to determine the daily amount of creatine supplement to be 
ingested by each participant, as well as to provide body composition data.  Initially, these 
measures were carried out using a BodPod Gold Standard Body Composition Tracking System, 
which determines percentage body fat and LBM using densitometry.  Following technical 
difficulties with the BodPod, participants‟ body mass was taken using a Model 1938 Toledo 
DigiTOL scale (Toledo Scale Corporation, Spartanburg, SC), and percentage body fat was 
determined using the Durnin-Womersley method (Durnin & Womersley, 1974).  This method 
uses the sum of four skinfolds (biceps, triceps, subscapular and iliac crest sites), which is 
converted to a percentage body fat using normative data from the 1988 Campbell‟s Survey on 
Well-Being in Canada, conducted by the Canadian Fitness and Lifestyle Research Institute 
(unpublished data, Canadian Society of Exercise Physiology [CSEP], 1996).  This method was 
chosen because it had been validated in both males and females between the ages of 16 and 72 
years. 
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3.2.4 Physical fitness assessments 
All fitness testing was preceded by a Physical Activity Readiness Questionnaire (PAR-Q) 
(refer to Appendix V), and for one participant who had a history of asthma, a Physical Activity 
Medical Examination (PARmed-X) (refer to Appendix VI).  Participants underwent pre and post 
treatment testing for muscular strength, anaerobic power, and total work performed during 
repeated isokinetic movements.  Aerobic fitness was tested prior to supplementation with 
vitamin B12, whereas the other fitness tests were performed during the week prior to and 
following creatine supplementation. 
3.2.4.1 Strength 
Strength testing was carried out using 1RM assessments for bench and leg press.  These 
tests were completed according to the “PFLC Resource Manual” (CSEP, 1996).  Participants 
were allowed three to five warm up repetitions at approximately 50 % of their estimated 1RM.  
They were then asked to lift the weights as quickly and with as much force as possible, while 
maintaining proper form.  The weight was progressively increased until the maximum weight 
was reached.  Two minutes of rest was allowed between each attempt in order to allow for ATP 
and phosphocreatine stores to restore.  Participants were allowed up to six attempts to determine 
their 1RM value (Chrusch, Chilibeck, Chad, Davison, & Burke, 2001). 
For the determination of 1RM bench press, a Hammer Strength barbell was used (Go 
Mango, Calgary, AB).  Each participant was instructed to lie on her back on the bench and grip 
the bar with her thumbs shoulder width apart with a closed overhand grip.  At the initiation of the 
attempt, the bar was even with the top of the chest, and the participant was asked to push the bar 
to full extension while keeping the buttocks on the bench and without arching the back. 
For the determination of 1RM leg press, the seat of a TechnoGym leg press machine 
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(TechnoGym USA Corp, Seattle, WA) was positioned so that the participant had a 90 
o
 starting 
angle at the knee with the foot flat on the pedals and the buttocks on the seat and the participant 
was then instructed to fully extend their legs without locking the knees. 
3.2.4.2 Anaerobic power 
Anaerobic power was assessed with repetitions of the Wingate anaerobic test (Bar-Or, 
1987).  This is a 30 second maximal performance test on a cycle ergometer.  The participant 
warmed up for five minutes on a stationary bicycle in order to attain a heart rate of 
approximately 150 beats per minute (bpm).  Following the warm up period, participants pedaled 
as hard as they could for a period of 30 seconds in a seated position against a resistance set at 
0.075 kiloponds per kilogram of body weight (Bulbulian, Jeong, & Murphy, 1996).  The 
resistance was applied when the participant was pedaling at maximal effort.  Three repetitions of 
the Wingate test were performed (Trial 1, 2, 3), separated by two minutes to allow time for 
phosphocreatine stores to be replenished.  Peak and average power outputs were derived from 
the Wingate tests.  Comparisons were made between each of the test repetitions, as well as 
between time points during the study.  Anaerobic capacity was determined using a Monark cycle 
ergometer (Monark, Sweden). 
3.2.4.3 Total work performed 
The total work performed during 50 isokinetic knee extensions was used as a measure of 
muscular endurance (Burke et al., 2003).  An isokinetic dynamometer (Biodex System 3, Biofit 
Medical, London, ON) was used, with an angular velocity of 180 
o
/second, and a range of motion 
of 90 to 170 degrees of flexion at the knee of the dominant leg (Burke et al., 2003).  Participants 
were stabilized in a sitting position with 85 degrees of flexion at the hip, and their back 
supported.  Stabilizing straps were placed across the chest, over the lap, and across the thigh of 
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the test leg.  Participants warmed up by completing ten repetitions of extension of the lower leg, 
followed by five minutes of rest before the test.  For the test the participants were asked to 
extend their lower leg as quickly and with as much force as possible for 50 repetitions, giving 
their maximal effort. 
3.2.4.4 Aerobic power 
Aerobic power was tested using a Sensormedic Vmax 29 series metabolic cart (Sensor 
Medics, Yorba Linda, CA) in accordance with the method of Thoden (1991) as slightly modified 
by the Canadian Society for Exercise Physiology (CSEP, 1996).  Participants were familiarized 
with the equipment at a walking pace (~5.0 km/hour) for two minutes, after which the speed of 
the treadmill (TechnoGym USA Corp, Seattle, WA), was increased to a jogging speed for three 
minutes to allow for a warm up before the test.  Participants finished the warm up period at a 
speed that they felt they could run at for 20 minutes if the treadmill were to remain at a 0 % 
grade.  The chosen speed was maintained and the grade increased by 2 % at the end of each two 
minute stage until the participant could no longer continue.  Expired gases were collected 
continuously throughout the test, and were analyzed for volume and percentage of oxygen and 
carbon dioxide. Twenty second averages were calculated from the breath by breath 
measurements.  Heart rate was measured, as well as ventilation volume, oxygen uptake (VO2), 
carbon dioxide output (VCO2) and the respiratory exchange ratio (RER) were calculated.  
Maximal oxygen uptake (VO2max) values were used to compare between groups.  VO2max was 
determined by a peak and plateau or decrease in breath by breath twenty second averages.  Other 
criteria used to determine that VO2max was achieved was a heart rate close to (generally within 
five beats per minute) or above the age predicted maximum, and a RER of 1.1 or greater (CSEP, 
1996). 
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3.2.5 Urine collection and analyses 
3.2.5.1 Urine collection 
Twenty-four hour urine samples were collected by the participants on day one and day 
seven of their second menstrual cycle (the intervention cycle).  These days represent the day 
before the initiation of, and the day following the cessation of creatine supplementation.  Along 
with a urine collection container (VWR International, Mississauga, ON), participants were given 
instructions on how to collect the 24 hour samples.  Twenty-four hour samples were required in 
order to avoid fluctuations due to time of day and water intake (Smith-Palmer, 2002).  
Participants were instructed to begin the collection with the second urination of the collection 
day, and to collect all subsequent urinations into the jug.  The importance of including each 
urination during the 24 hour collection period was stressed with each participant.  Each urination 
up to and including the first urination of the following day (day two of the cycle) was collected 
in the jug.  Participants were given instructions to keep the urine collection jug securely closed in 
order to prevent leakage and contamination of the sample, and to keep the sample out of direct 
sunlight. 
3.2.5.2 Urine analyses 
An aliquot of urine was removed from the collection container after the sample was 
mixed and the volume recorded.  The aliquots were frozen at -80 
o
C until further analyses could 
be completed.  Samples were diluted 100 fold prior to analysis (Burke et al., 2001), and were 
analyzed for the presence of creatine and creatinine.  The analyses were conducted using high 
performance liquid chromatography (HPLC), using a potassium phosphate and TBAHS (2.0 g : 
0.8 g) adjusted to pH 5.0 with aqueous potassium hydroxide (Burke et al., 2001).  Analyses were 
carried out using a Waters 600 controller, a Waters 486 Tunable Absorbance Detector, and a 
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Waters 715 Ultra WISP sample processor.  Twenty microlitres (µL) of supernatant was injected 
into a 250 x 3.0 mm Varian column for each trial, and concentrations were determined from their 
peak heights in comparison to a standard curve. The standard curve was derived using creatine 
and creatinine standards of concentrations between one and 500 µmol and was created with 
Milennium 32 Software.  A standard was run after every five samples (Burke et al., 2001).  
Reproducibility for this method has been reported to be ± 1.0 % for creatine and ± 1.4 % for 
creatinine (MacNeil et al., 2005). 
3.2.6 Blood collection and analyses 
3.2.6.1 Blood collection 
All blood collections were performed according to the recommendations of Refsum and 
colleagues (1998).  Blood was drawn in the morning in an overnight fasted state; with the 
participant sitting with a standardized posture so as not to affect albumin concentration (a 
determinant of protein bound Hcy).  Hematocrit values were measured using a Thermo IEC 
Micro-MB microcentrifuge (Fisher Scientific, Nepean, ON) prior to each blood collection in 
order to ensure that any concentration changes were not a result of changes in blood volume.  
Blood samples were collected from an antecubital vein of each participant into chilled vacutainer 
tubes (VWR International, Inc., Edmonton, AB) using venipuncture techniques (Garza & Becan-
McBride, 2002). 
Collections were made on the morning of the initiation of the creatine loading phase, 
prior to the ingestion of the first supplement, in order to determine baseline concentrations of the 
hematological components of interest.  Blood was again collected on the morning of day seven 
of the menstrual cycle, or the morning following the cessation of the creatine loading period 
(following the same procedures).  Three tubes containing approximately 6 mL of whole blood 
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each were removed during each collection. 
3.2.6.2 Serum homocysteine 
Serum Hcy concentrations were analyzed using a commercially available Immulite 2500 
Competitive Immunoassay kit (Diagnostic Products Corporation, Los Angeles, CA) at The 
Provincial Laboratory (Regina, Saskatchewan).  Samples were collected in Serum Plus Blood 
Collection vacutainer tubes, and centrifuged following the clotting period, in order to separate 
the red cells and serum.  The samples were centrifuged for 15 minutes at 5,710 times gravity 
using an Allegra 6R RFG centrifuge at approximately 4 
o
C (VWR International Inc, Edmonton, 
AB) following clotting.  The serum was removed and frozen for later analysis.  Serum samples 
have been reported to remain stable when kept frozen at -20 
o
C for six months for Hcy analyses 
in the Immulite 2500 Competitive Immunoassay kit (refer to Appendix VII). 
The immunoassay kit uses chemiluminescence to detect the amount of a particular 
component in a sample, which in this case is the amount of Hcy in human serum.  The assay kit 
involves two 30 minute incubation cycles.  The first cycle involves pretreating the serum with 
SAH hydrolase and dithiothreitol (DTT) solution.  The second cycle involves moving the sample 
to a second reaction tube, containing a SAH-coated polystyrene bead and an alkaline phosphate-
labeled antibody specific for SAH.  Finally, the sample is washed to remove any unbound 
enzyme conjugate.  Diagnostic Products Corporation reports a coefficient of variation range 
between 3.4 and 7.4 % within run, and a total range between 4.1 and 10.4 %. 
3.2.6.3 Serum B12 
Analyses of serum B12 concentrations were carried out using an Architect B12 Assay 
(Abbott Laboratories, Abbott Park, IL, refer to Appendix VII) at the Provincial Laboratory.  
Samples were collected in Serum Plus Blood Collection vacutainer tubes, and centrifuged 
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following the clotting period, in order to separate the red cells and serum.  Blood samples to be 
used for vitamin B12 analysis were kept in a dimly lit area for the process of centrifugation.  This 
has been found to prevent loss or degradation of the substance, as vitamin B12 has been reported 
to be unstable in the light (Briddon, 2003).  Following removal, serum samples were stored at -
80 
o
C for up to 78 days before they were batch analyzed. 
The samples were first incubated with sodium hydroxide with potassium cyanide, alpha 
monothioglycerol and EDTA, and cobinamide dycyanide in borate buffer with protein 
stabilizers.  Following incubation, microparticles (porcine coated microparticles in borate buffer) 
and assay diluent (borate buffer with EDTA) were mixed in; the sample was again incubated, 
and then washed.  A B12 acridinium-labeled conjugate in MES buffer was added, and the sample 
was again mixed, incubated and washed.  Pre trigger (hydrogen peroxide) and trigger (sodium 
hydroxide) solutions were added, and the chemiluminescent emission was measured to determine 
the quantity of vitamin B12 in the sample.  The within run coefficient of variation reported ranged 
between 3.7 and 8.4 %, while the total coefficient of variation ranged from 5.3 to 9.5 %. 
3.2.6.4 Plasma B6 
Samples for B6 (measured as pyridoxal 5‟-phosphate) analysis were collected in EDTA 
vacutainer tubes, and immediately centrifuged for 15 minutes.  Following centrifugation, the 
plasma was removed and frozen at -80 
o
C until further analysis at the Provincial Laboratory. 
Analysis of plasma B6 concentrations were carried out using Hewlett Packard 1100 series 
system high performance liquid chromatography (HPLC) with a degasser and fitted with a diode 
array detector.  Samples were analyzed according to procedures outlined by Deitrick, Katholi, 
Huddleston, Hardiek and Burrus (2001).  Briefly, protein free plasma samples were prepared by 
protein precipitation using perchloric acid.  The samples were then injected into the HPLC 
 51 
 
system with two mobile phases (A and B).  The Mobile phase A was a 0.1 mol/L potassium 
dihydrogen phosphate buffer, and mobile phase B was a 30 % acetonitrile and water buffer.  For 
quantification, the peak area from each sample was used as compared with a standard calibration 
curve for vitamin B6.  The coefficient of variation for this method was reported to fall between 
1.10 and 2.36 % (Deitrick et al., 2001). 
3.2.6.5 Whole blood folate 
Whole blood samples used for the determination of folate concentration were collected in 
EDTA tubes, and kept refrigerated for less than seven days until analysis, as recommended in the 
immunoassay kit.  Samples were analyzed at the Provincial Laboratory using an Abbott 
Competitive Immunoassay Kit on an Architech i2000 instrument (refer to Appendix VII).  The 
assay determines folate concentration using Chemiluminescent Microparticle Immunoassay 
technology. 
The whole blood sample was first mixed with DTT in acetic acid buffer with EDTA, 
followed by incubation.  Next, the sample was mixed and incubated with potassium hydroxide, 
followed by the addition of microparticles (anti-folate binding protein coupled to microparticles 
with affinity bound with folate binding protein in TRIS buffer) and assay specific diluents 
(borate buffer).  The samples were mixed, incubated and washed.  Conjugate (Pteroic acid-
acridinium labeled conjugate in MES buffer) was added and the samples were mixed, incubated 
and washed again.  Pre-trigger (hydrogen peroxide) and trigger (sodium hydroxide) solutions 
were added, and the chemiluminescent emission was measured to determine the quantity of 
folate in the sample.  Abbott Laboratories reported a within run coefficient of variation ranging 
from 1.4 to 6.2 %, and a total coefficient of variation between 2.7 and 9.5 %. 
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3.2.7 Statistical analyses 
Following calculations of descriptive statistics for each of the dependent variables, 
outliers were removed for all measures except for dietary intake.  Outliers were determined by 
distinguishing which dependent variables were skewed (skewness/standard error > ± 2.5), which 
violates the assumption of normality within the population. The dependent variables were also 
plotted in box plots using SPSS 16.0 (SPSS Inc. Headquarters, Chicago, IL).  Data that was 
identified as an outlier in the box plot by the statistical program, that was also from a skewed 
population was removed before further analysis. 
Independent samples t tests were used to make comparisons between groups for aerobic 
fitness (VO2max), daily amount of creatine ingested, and nutritional intake reported in the food 
diaries.  The average dietary intakes of vitamin B2, B6, B12 and folate were compared between 
groups to ensure that there were no significant differences in dietary components that could have 
an effect on the resulting plasma or serum concentrations of vitamin B12 or Hcy.  Comparisons of 
energy, protein, carbohydrate, fat, cholesterol and creatine intake between groups were also 
carried out.  Oral contraceptive use was compared between groups using Fisher‟s exact test, due 
to the small sample sizes.  Two factor analysis of variance (2 x 2 factorial ANOVA) with a 
between groups factor (vegetarian vs. non-vegetarian) and a repeated measures factor (pre vs. 
post-supplementation) was used to analyze mass and percent fat, bench and leg press strength, 
peak torque and average power during leg extensions, hematocrit, plasma concentrations of 
vitamin B6, serum concentrations of vitamin B12 and Hcy, whole blood measures of folate, and 
urinary creatine and creatinine.  Comparisons between vegetarians and non-vegetarians for 
change score on leg press were made using a one factor ANOVA.  Comparisons of peak and 
average power were made using 2 (group) x 2 (time) x 3 (set) factorial ANOVAs, with repeated 
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measures on the last two factors, followed by a Bonferroni post hoc test.  A p value of 0.05 was 
used to determine significance. 
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4. RESULTS 
4.1 Participant characteristics 
Twenty healthy females between the ages of 18 and 40 volunteered to participate in the 
current study.  All claimed to be recreationally active, that they were non smokers, had regular 
menstrual cycles, and were healthy individuals, free from disease.  Each participant also 
indicated that they did not take medications for reasons other than birth control. 
4.1.1 Age, height and oral contraceptive use 
Age (p = 0.557), oral contraceptive use (p = 0.197) and height (p = 0.607) were not 
different between vegetarian and non-vegetarian participants (Table 4.1). 
4.1.2 Baseline aerobic fitness 
Baseline aerobic fitness levels were not statistically different between vegetarian and 
non-vegetarian participants (p = 0.167, Table 4.1). 
4.1.3 Dietary intake 
Analyses of dietary intake (Table 4.2) revealed no significant differences between groups 
for protein (p = 0.14), carbohydrate (p = 0.075) or fat (p = 0.107) intake.  No significant 
differences between groups for energy intake (p = 0.59), vitamin B2 (p = 0.304), vitamin B6 (p = 
0.82), vitamin B12 (p = 0.245), total folate (p = 0.602) iron (p = 0.87), or methionine (p = 0.15) 
were found.  Dietary intake of cholesterol was also found to differ (p = 0.025) between groups.  
There was a significant difference in creatine intake between groups (p = 0.001).
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Table 4.1. Participant characteristics for vegetarian (VG) and non-vegetarian (NV) groups. 
Measure Vegetarian (n = 9) Non-Vegetarian (n = 11) 
Age (years) 25.4 ± 3.6 24.1 ± 5.9 
Height (cm) 164.8 ± 5.7 163.3 ± 6.8 
Oral contraceptive use 
(% using) 
22.2 54.5 
Aerobic fitness 
(ml·O2 kg
-1
·min
-1
) 
43.1 ± 5.4 47.2 ± 7.1 
Creatine supplement 
(g d
-1
) 
11.2 ± 1.0 11.57 ± 1.2 
 
Baseline measures were analyzed using independent sample t tests (p < 0.05).  nVG = 9, nNV = 11.  
Values are means ± standard deviation. 
4.1.4 Creatine supplementation 
Groups were not different for the daily amount of measured creatine supplementation 
given (p = 0.512, Table 4.1). 
4.1.5 Body composition 
Body mass did not differ significantly between dietary groups at either time point (p = 
0.170, Table 4.3).  When data were pooled however, there was a significant time effect of 
creatine supplementation on body mass (p = 0.017). 
Vegetarians had higher percentage body fat at the onset of the study when compared to 
non-vegetarians (p = 0.001, Table 4.3).  There was no significant effect of creatine 
supplementation on body fat in either group (p = 0.512).  Body composition measures using 
BodPod were completed for seven vegetarians and six non-vegetarians. 
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Table 4.2. Dietary intake from foods for vegetarian (VG) and non-vegetarian (NV) groups. 
Measure Vegetarian Non-Vegetarian 
Energy (kcal) 2233 ± 435 2106 ± 566 
Vitamin B2 (mg) 1.4 ± 0.9 3.5 ± 6.0 
Vitamin B6 (mg) 1.2 ± 0.8 1.3 ± 0.5 
Total folate (µg) 228 ± 176 261 ± 104
a
 
Vitamin B12 (µg) 2.4 ± 2.8 4.0 ± 1.8
a
 
Iron (mg) 16.4 ± 5.8 15.9 ± 7.8 
Methionine (g) 0.5 ± 0.3 0.7 ± 0.5 
Protein (g) 73.0 ± 12.4 86.1 ± 22.7 
Carbohydrate (g) 320 ± 80 253 ± 77 
Fat (g) 65 ± 23 86 ± 33 
Cholesterol (mg) 88 ±72 279 ± 173
a
 
Creatine (g) 0.02 ± 0.03 0.50 ± 0.33
a
 
 
Independent sample t tests were used to compare between vegetarians and non-vegetarians for 
nutritional intake.  
a
: Significant effect of diet (p < 0.05).  nVG = 9, nNV = 11.  Values are means ± 
standard deviation. 
4.2 Fitness results 
4.2.1 Leg extensions 
A significant main effect of time on absolute peak torque was observed (p = 0.002, Table 
4.4), indicating an increase in peak torque for pooled participants.  The response to creatine was 
not significantly different between groups (p = 0.339).  There was also a significant main effect 
of time on absolute average power (p = 0.002), whereby the pooled participants increased over 
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time (Table 4.4).  However, with respect to this measure, vegetarians and non-vegetarians did not 
respond differently to the supplement (p = 0.667). 
Table 4.3. Body mass and percentage fat for vegetarians (VG), non-vegetarians (NV), and 
participants pooled by time point. 
Measure Pre (VG) Post (VG) Pre (NV) Post (NV) Pre 
(pooled) 
Post 
(pooled) 
Body Mass 
(kg) 
63.5 ± 6.3 64.0 ± 6.6 60.0 ± 4.8 60.3 ± 4.9 61.6 ± 5.7 62.0 ± 5.9
a
 
Body Fat 
(%) (nVG = 
7, nNV = 6) 
28.9 ± 2.5 28.1 ± 3.0 20.2 ± 3.7
b
 22.5 ± 4.7
c
 24.9 ± 5.4 25.5 ± 4.7 
 
Comparisons of body mass and fat were made using two by two factorial ANOVAs.  For each 
analysis, time (pre and post) and dietary group (VG and NV) were used as factors.  
a
: Significant 
effect of time (p < 0.05); 
b
: Significant effect of diet at onset of study (p < 0.05); 
c
: Significant 
effect of diet during post measures (p < 0.05).  nVG = 9, nNV = 11 unless otherwise indicated.  
Pooled values include vegetarian and non-vegetarian data.  Values are means ± standard 
deviation. 
4.2.2 Strength 
Strength assessed by bench press was significantly affected over time (p = 0.001, Table 
4.5), as indicated by an increase in one repetition maximum in response to creatine 
supplementation.  Performance on one repetition maximum bench press did not differ between 
vegetarians or non-vegetarians (p = 0.105). 
A significant effect of time on strength assessed by one repetition maximum of leg press 
was also found (p = 0.003, Table 4.5).  There was a significant dietary condition by time 
interaction whereby vegetarians increased more than non-vegetarians (p = 0.035), though the 
difference between groups post-supplementation was not significant (p = 0.374).  Comparisons 
of change scores from the leg press measures revealed that there was a significant effect of diet 
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on strength assessed by leg press (p = 0.035), whereby vegetarians experienced an increase of 16 
± 16 vs. 3 ± 9 kg. 
Table 4.4. Peak torque and average power during 50 repetitions of leg extension on a 
BioDex dynamometer for vegetarians (VG), non-vegetarians (NV), and participants pooled 
by time point. 
Measure Pre (VG) Post (VG) Pre (NV) Post (NV) Pre 
(pooled) 
Post 
(pooled) 
Peak 
Torque 
(Nm) 
80.3 ± 11.3 90.1 ± 8.1 89.0 ± 17.1 93.1 ± 16.1 85.1 ± 15.0 91.8 ± 
12.9
a
 
Average 
Power (W) 
(nVG = 9, 
nNV = 10) 
100.7 ± 
17.6 
108.9 ± 
15.3 
98.4 ± 11.8 105.5 ± 
14.9 
99.5 ± 14.4 107.1 ± 
14.8
a
 
 
Two by two factorial ANOVAs were used to compare pre and post measures (for VG and NV) 
of peak torque and average power during fifty repetitions of a leg extension using a Biodex 
isokinetic dynamometer.  
a
: Significant effect of time (p < 0.05).  nVG = 9, nNV = 11 unless 
otherwise indicated.  Pooled values include vegetarian and non-vegetarian data.  Values are 
means ± standard deviations. 
4.2.3 Repeated Wingates 
The response to creatine supplementation as reflected by peak power during repetitions of 
Wingate tests was not different between vegetarians and non-vegetarians (p = 0.793, Table 4.6).  
When the groups and trials were pooled, peak power was found to increase following the 
intervention (p = 0.025; 449 ± 93 vs. 472 ± 104 W), though there was no change in average 
power in response to creatine supplementation (p = 0.755; 345 ± 73 vs. 348 ± 81 W).  A 
significant effect of trial on peak power was found when groups and time points were pooled (p 
< 0.001).  Post hoc analyses using a Bonferroni adjustment revealed decreases in peak power 
between trial 1 and 2 (p < 0.001; 506 ± 95 vs. 447 ± 98 W), and decreases between trial 1 and 3 
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(p < 0.001; 506 ± 95 vs. 430 ± 88 W), but no significant differences between trial 2 and 3 (p = 
0.231).  No significant interactions were found between trial and diet (p = 0.654), time and trial 
(p = 0.554) or time, trial and diet (p = 0.714). 
A significant main effect of trial on average power during Wingate tests, when groups 
and time points were pooled was found (p < 0.001).  Post hoc analyses using a Bonferroni 
adjustment revealed decreases in average power between trial 1 and 2 (p < 0.001; 393 ± 69 vs. 
336 ± 72 W), between trial 1 and 3 (p < 0.001; 393 ± 69 vs. 311 ± 67 W), and between trial 2 and 
3 (p < 0.001).  However, there were no differences between vegetarians and non-vegetarians in 
response to the intervention (p = 0.839), and there was not a significant effect of time (p = 
0.755).  Finally, there were no significant interactions between time and diet (p = 0.449), trial 
and diet (p = 0.062), time and trial (p = 0.775) or time, trial and diet (p = 0.108). 
Table 4.5. One repetition maximum for bench and leg press for vegetarians (VG), non-
vegetarians (NV), and participants pooled by time point. 
Measure Pre (VG) Post (VG) Pre (NV) Post (NV) Pre 
(pooled) 
Post 
(pooled) 
1RM 
Bench 
Press (kg) 
45 ± 7 43 ± 8 49 ± 15 52 ± 14 45 ± 13 48 ± 12
a
 
1RM Leg 
Press (kg) 
121 ± 43 137  ± 48 112 ± 29 115± 31 116± 35 125 ± 40
a
 
 
Strength assessed by a one repetition maximum (1RM) bench press and leg press was compared 
using two by two factorial ANOVAs.  Factors included were time (pre and post) and dietary 
group (VG vs. NV).  
a
: Significant effect of time (p < 0.05).  nVG = 9, nNV = 11 unless otherwise 
indicated.  Pooled values include vegetarian and non-vegetarian data.  Values are means ± 
standard deviations. 
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Table 4.6. Peak and average power during three repetitions of a Wingate anaerobic test for 
vegetarians (VG), non-vegetarians (NV), and participants pooled by time point. 
Measure Pre-test: 
T1 
Pre-test: 
T2 
Pre-test: 
T3 
Post-test: 
T1 
Post-test: 
T2 
Post-test: 
T3 
Peak Power 
(W): VG 
485 ± 77 436 ± 81 419 ± 106 514 ± 85 453 ± 117 434 ± 106 
Peak Power 
(W): NV 
503 ± 101 434 ± 97 426 ± 80 527 ± 115. 464 ± 105 439 ± 74 
Peak Power 
(W): pooled 
490 ± 90 435 ± 88 423 ± 90 521 ± 100 459 ± 108 437 ± 87 
Average 
Power (W): 
VG 
376 ± 58 339 ± 64 319 ± 71 384 ± 81 334 ± 90 305 ± 76 
Average 
Power (W): 
NV 
404 ± 70 329 ± 72 303 ± 64 402 ± 73 343 ± 71 315 ± 67 
Average 
Power (W): 
pooled 
391 ± 65 334 ± 67 310 ± 66 394 ± 76 339 ± 78 311 ± 69 
 
Peak and average power measures were compared between dietary groups, over time (pre and 
post) and by repetition (trials 1, 2, 3) using two by two by three factorial ANOVAs (p < 0.05).  
nVG = 9, nNV = 11 unless otherwise indicated.  Pooled values include vegetarian and non-
vegetarian data.  Values are means ± standard deviations. 
4.3 Blood measures 
4.3.1 Hematocrit 
A significant interaction between time and diet was found (p = 0.047, Table 4.7).  
Independent samples t tests revealed that vegetarian participants had lower hematocrit values 
prior to the intervention (p < 0.001) but not following (p = 0.49). 
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4.3.2 Serum homocysteine 
Creatine did not have a significant effect on serum Hcy concentration across time (p = 
0.21, Table 4.7) or by dietary classification (p = 0.28). 
4.3.3 Vitamins in blood 
 Plasma concentrations of vitamin B6 were significantly affected over time (p = 0.001, 
Table 4.7).  The pooled population experienced an increase in vitamin B6 concentration.  
However, vegetarians and non-vegetarians did not respond differently to creatine 
supplementation (p = 0.869). 
No significant differences were found in response to creatine supplementation for whole 
blood folate (p = 0.448, Table 4.7) or serum concentrations of vitamin B12 (p = 0.301, Table 4.7).  
Vegetarians and non-vegetarians did not respond differently to the intervention for whole blood 
folate (p = 0.303) or vitamin B12 (p = 0.489). 
4.4 Urinary measures 
4.4.1 Urinary creatine and creatinine 
A main effect of time for urinary creatine concentration was evident (p < 0.001, Table 
4.8), whereby the grouped participants experienced an increase in response to creatine 
supplementation.  Baseline concentrations of urinary creatine were not different for vegetarians 
and non-vegetarians.  Also, the response to creatine supplementation was not significantly 
different between groups (p = 0.357).  No differences were found in urinary creatinine 
concentration in response to creatine supplementation (p = 0.628, Table 4.8).  Finally, the urinary 
creatinine response was not different for vegetarians and non-vegetarians (p = 0.890). 
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Table 4.7. Blood measures for vegetarians (VG), non-vegetarians (NV), and participants 
pooled by time point. 
Measure Pre (VG) Post 
(VG) 
Pre (NV) Post 
(NV) 
Pre 
(pooled) 
Post 
(pooled) 
Hematocrit 
(%) 
35.4 ± 2.6 38.9 ± 4.2 39.6 ± 
1.2
a
 
40.0 ± 2.4 37.7 ± 2.8 39.5 ± 3.3
b
 
Serum Hcy 
(µmol/L) 
6.3 ± 1.7 6.9 ± 1.7 5.7 ± 1.9 5.9 ± 1.7 5.9 ± 1.8 6.3 ± 1.7 
Plasma B6 
(nmol/L) 
78.8 ± 
23.0 
89.9 ± 
25.8 
67.0 ± 
26.2 
98.5 ± 
23.3 
72.3 ± 
24.9 
94.7 ± 
24.2
b
 
WB folate 
(nmol/L) 
1480.9 ± 
279.6 
1388.7 ± 
391.3 
1341.3 ± 
279.0 
1306.6 ± 
225.7 
1404.1 ± 
281.0 
1343.5 ± 
305.0 
Serum B12 
(pmol/L) 
(nVG = 8, 
nNV = 11) 
294.3 ± 
261.9 
217.0 ± 
142.4 
322.0 ± 
171.0 
276.7 ± 
144.5 
310.3 ± 
207.6 
251.6 ± 
142.8 
 
Blood measure comparisons were made between dietary groups (VG and NV) and over time (pre 
and post) using two by two factorial ANOVAs.  
a
: Significant effect of diet (p < 0.05); 
b
: 
Significant effect of time (p < 0.05).  WB = whole blood.  nVG = 9, nNV = 11 unless otherwise 
indicated.  Pooled values include vegetarian and non-vegetarian data.  Values are means ± 
standard deviations. 
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Table 4.8. Creatine (Cr) and creatinine (Cn) measures in urine for vegetarians (VG), non-
vegetarians (NV), and participants pooled by time point. 
Measure Pre (VG) Post 
(VG) 
Pre (NV) Post (NV) Pre 
(pooled) 
Post 
(pooled) 
Urine Cr 
(µmol) 
(nVG = 8, 
nNV = 11) 
76.6 ± 
84.9 
537.4 ± 
255.8 
84.8 ± 
136.6 
736.9 ± 
513.8 
81.1 ± 
113.5 
647.1 ± 
420.5
a
 
Urine Cn 
(µmol) 
10308 ± 
4290 
10479 ± 
2893 
10256 ± 
5185 
11063 ± 
5688 
10279 ± 
4680 
10800 ± 
4543 
 
Two by two factorial ANOVAs (between dietary groups and over time) were used to compare 
urinary creatine and urinary creatinine outputs.  
a
: Significant effect of time (p < 0.05).  nVG = 9, 
nNV = 11 unless otherwise indicated.  Pooled values include vegetarian and non-vegetarian data.  
Values are means ± standard deviations. 
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5.0 DISCUSSION 
Homocysteine has been linked with cardiovascular disease when found in high 
concentration in the bloodstream, though no causative role has been distinguished (Selhub, 
1999).  Homocysteine metabolism involves the methylation of a number of compounds, 
including the formation of creatine from guanidinoacetate (Taes et al., 2003).  Following the 
methyl donation, Hcy is reformed.  The purpose of this research was to determine whether five 
days of oral supplementation with the popular sports supplement creatine monohydrate (0.25 g 
Cr/kg LBM per day) elicits a change in serum concentration of Hcy and/or changes in selected 
fitness measures in vegetarian and non-vegetarian females.  Individuals following a lacto-ovo 
vegetarian or vegan diet have increased concentrations of Hcy in the bloodstream when 
compared to non-vegetarian counterparts (Obeid et al., 2002).  While this is due to decreased 
dietary intake of natural sources of vitamin B12 (Barr & Rideout, 2004), it is possible that the 
lack of dietary creatine may be a contributing factor.  However, in the current study, there were 
no differences in urinary creatine output between groups prior to or following the creatine 
intervention.  Because the groups were at similar concentrations prior to supplementation, it was 
unlikely that differences in response to creatine would be present. 
While increases in urinary creatine output were noted which would be indicative of a 
positive response to the loading protocol per se, serum Hcy concentration was not affected by 
creatine supplementation.  There was no effect of diet on urinary creatine at baseline or 
following the supplementation period.  When pooled, participants experienced a performance 
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improvement in strength assessed by a 1RM bench press and leg press, improved their peak 
torque and average power during fifty repetitions of the leg extension, and improved their peak 
power during three repetitions of the Wingate anaerobic test, in response to the creatine 
supplementation protocol. 
Dietary intake was analyzed in order to identify any differences between groups that may 
have an effect on serum concentration of Hcy.  Given the importance of the vitamins B2, B6, B12 
and folate in the metabolism of Hcy, either in the formation of methionine, or in the disposal of 
Hcy through the transsulphuration pathway (Selhub, 1999) it was important to discern any 
baseline differences in these micronutrients.  Deficiencies of vitamin B12 and folate increase Hcy 
concentration in the bloodstream.  In the current study, no differences in dietary intake of these 
vitamins were noted prior to the supplementation period. 
Although the mean values for both groups satisfied the recommended daily allowance 
(RDA) intake for vitamin B2 (1.1 mg per day) (Institute of Medicine: Food and Nutrition Board, 
1998) only five of the nine vegetarian participants met the RDA, whereas all but one of the non-
vegetarian participants met or surpassed this recommendation.  Three participants in total (one 
vegetarian, two non-vegetarians) met the RDA of 400 µg per day of folate.  The mean values 
conform to previous findings that vegetarians consumed the same amount of vitamin B2 and 
folate when compared to non-vegetarians over a seven day period (Millet, Guilland, Fuchs, & 
Klepping, 1989).  Eleven participants (two vegetarians, nine non-vegetarians) consumed enough 
vitamin B12 daily to satisfy the RDA values (2.4 µg per day).  It is important to note however, 
that each participant was supplementing with 25 µg of vitamin B12, to ensure that deficiencies 
would not be a factor affecting serum concentrations of Hcy.  While the mean intake reported for 
the vegetarian participants satisfies the RDA recommendation, non-vegetarians reported 
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ingesting 1.5 times the RDA for vitamin B12.  Also, RDA values may not reflect the true 
requirement of an individual for the particular nutrient of interest (Institute of Medicine of the 
National Academies, 2006).  Though an individual may not satisfy the RDA values, they may 
still be including sufficient quantities in their diet for their own requirements. 
In the case of folate and vitamin B12, fortified or enriched foods were not reported as 
such, and therefore were not included in the dietary analysis.  Food diaries (refer to Appendix 
IV) are often used as a source of information about nutritional intake, though reports of the 
reliability of self reporting reveal that energy intake and portion sizes are generally 
underreported (Howat et al., 1994).  Dietary intake was used in the current study to determine 
whether there were differences between vegetarians and non-vegetarians for nutrients of interest, 
and to use as a benchmark for participants‟ dietary intake throughout the study.  Participants 
were given instructions on the completion of food diaries, and were encouraged to include as 
much information as possible.  However, participants did not include information about 
fortification.  Fortified foods may not have been specified in their records, since instructions to 
include information in the food diaries about fortification in products were not given.  This 
weakness would be a factor in both groups, though the greatest impact with regard to vitamin B12 
might be noted in the vegetarian group. 
With vegetarian products, fortified foods were likely included in their diets, since most 
popular processed protein options for vegetarians include supplemental vitamin B12.  Many 
vegetarian burgers, textured proteins, soy milks, vegetable and sunflower margarines and 
breakfast cereals are fortified with vitamin B12.  Also, vitamin B2, folate and vitamin B12 are 
available naturally in a variety of foods.  Folate can be found in high quantities in beans, spinach, 
romaine lettuce, orange and pineapple juice, many fruits and berries, nuts, and vegetables.  
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Vitamins B2 and B12 are found naturally in meat, dairy products and eggs.  Vitamin B2 can also 
be found in green leafy vegetables, enriched and whole grains and cereals, nuts and fruits.  While 
the NutriBase software includes folate fortification for vegetarian products, it may not accurately 
assess quantities of vitamins B2 or B12 fortification (CyberSoft, Inc., 2006).  Nutritional 
information was derived from the USDA Nutrient Database for Standard Reference and Brand 
Name foods, and the Canadian Nutrient Files. 
Both vegetarians and non-vegetarians had normal concentrations of whole blood folate 
and serum vitamin B12.  Normal values for whole blood folate are greater than 317 nmol/L 
(Bailey, 1990), and for serum concentrations of vitamin B12 are greater than 150 pmol/L (Millet 
et al., 1989).  Values in the current study meet these criteria. 
Also, there was no effect of creatine on whole blood folate or serum B12 concentration.  
While creatine, folate and B12 are all involved in Hcy metabolism, they are involved in different 
metabolic pathways.  Creatine is created as a result of the methylation of guanidinoacetate, 
whereas folate and B12 are involved as cofactors in the methylation of Hcy to form methionine 
(Korzun, 2004; Selhub, 1999). 
No differences were found in energy intake, vitamin B6, iron or methionine.  
Interestingly, mean values for iron intake were slightly, but not significantly, higher for 
vegetarian participants.  Each group reported ingesting slightly less than the 18 mg RDA for iron 
(Institute of Medicine: Food and Nutrition Board, 1998).  Though the general belief is that iron is 
found in the highest concentration in meat and seafood, beans, tofu, a variety of seeds, and 
enriched breakfast cereals each have greater amounts of iron per serving size than meats.  
Nieman (1999) states that iron intake in vegetarians is generally above the recommended 
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amount, though nonheme iron from plant food sources is not as readily absorbed as heme iron 
from animal products, resulting in decreased concentrations in the bloodstream.  While 
vegetarians reported consuming a number of sources of nonheme iron, their reported intake 
remained slightly below the RDA. 
Vegetarian participants in the current study made an effort to include these nonheme iron 
concentrated foods and other nutrients and vitamins in their diet, which therefore resulted in 
similar intakes when compared to non-vegetarians.  This agrees with conclusions made by Millet 
and colleagues (1989), that vegetarians may be more diet-conscious than non-vegetarians. 
Hematocrit values are often used as an indicator of iron status.  The vegetarians in the 
current study had significantly lower hematocrit values when compared with non-vegetarians, 
suggesting that they were not absorbing enough nonheme iron.  Iron is fundamental in both 
oxygen delivery and utilization during aerobic exercise (Lukaski, 2004).  However, diet, along 
with differences in hematocrit values, did not result in significant differences in aerobic fitness, 
as measured by the VO2max test.  Differences in hematocrit across time are likely due to 
differences in hydration status. 
Vegetarian participants satisfied the Acceptable Macronutrient Distribution Ranges for 
protein (13 ± 2 vs. 10 – 35 %), carbohydrate (59 ± 7 vs. 45 – 65 %) and fat (25 ± 6 vs. 20 – 35 
%) intake (Institute of Medicine of the National Academies, 2006).  Non-vegetarians complied 
with these guidelines for protein (16 ± 3 %) and carbohydrate (47 ± 8 %) intake, though the 
mean value for fat was slightly greater than the recommended range (36 ± 8 %).  When protein 
intake relative to body weight (g/kg) was compared between vegetarians and non-vegetarians, no 
differences were found.  Both groups satisfied the RDA values (0.80 g/kg/day).  Significant 
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differences were found between groups for cholesterol intake.  Non-vegetarian participants had 
greater cholesterol intake when compared to vegetarians, which is likely a result of the high 
amounts present in foods of animal origin (Institute of Medicine of the National Academies, 
2006). 
Dietary intake of creatine via animal products in the diet was significantly different 
between groups.  Non-vegetarians, who ingest meat and fish, were found to have significantly 
higher dietary creatine intake when compared to vegetarians.  This was expected, since 
vegetarians have only milk and cranberries available to them, each of which have very small 
creatine content (milk: 0.1 g/kg; cranberries, 0.02 g/kg).  No intake of cranberries was listed in 
the food diaries.  While non-vegetarians consumed greater amounts of creatine in the diet, their 
intake remained lower than expected (Bemben & Lamont, 2005).  Bemben and Lamont (2005) 
report that a normal mixed diet includes approximately 1 gram of creatine per day, which is 
twice the average intake in the current work.  The non-vegetarian females in this study did not 
ingest animal tissues with each meal, nor did some of them ingest animal tissues every day, 
thereby limiting the intake of creatine in the diet.  This low dietary intake likely had an effect on 
urinary creatine output, decreasing the difference between vegetarians and non-vegetarians and 
resulting in non-significant baseline concentration. 
In the current study, twenty healthy females supplemented with creatine (0.25 g Cr/kg 
LBM) for a period of five days.  The rationale for supplementing with creatine was to examine 
the serum Hcy response to creatine supplementation.  It was thought that Hcy production would 
be decreased due to a diminished need for endogenous production of creatine (Taes et al., 2003).  
The healthy females involved in the current project did not experience a change in serum Hcy 
concentration in response to a five day loading phase of creatine supplementation.  In fact, 
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though there was no trend (p = 0.214), the mean values increased slightly from the onset of the 
intervention to the conclusion.  If creatine supplementation has a Hcy lowering effect, such a 
response could occur only in those with elevated Hcy concentration at the onset of 
supplementation.  Homocysteine concentration in the vegetarian participants was lower than 
expected, since previous research has established that vegetarians have higher Hcy concentration 
in the bloodstream than non-vegetarian counterparts (Bissoli et al., 2002; Herrmann et al., 2001; 
Hung et al., 2002; Krajcovicova-Kudlackova et al., 2000; Obeid et al., 2002).  In fact, Hcy 
concentration found in the current study was lower in both vegetarians and non-vegetarians when 
compared to these previous studies, which suggests not only that the participants were very 
healthy, but that they had ample vitamin B12 and folate available for Hcy metabolism.  Therefore, 
further decreases in Hcy concentration in the bloodstream would be unlikely to occur. 
The fact that these healthy females did not experience decreases in Hcy concentration 
falls in line with previous research examining healthy (Steenge et al., 2001) and unhealthy 
individuals (Taes et al., 2004).  Steenge et al. (2001) had healthy female participants load with 
creatine for five days (20 g Cr/day), then ingest three grams each day for an additional eight 
weeks.  While there was a trend towards a decrease in Hcy concentration, statistical significance 
was not achieved.  Homocysteine concentration prior to the intervention was not particularly 
elevated (~9.5 µmol/L), though they were greater than the values found in the current work. 
Taes et al. (2004) investigated the Hcy response to creatine supplementation for four 
weeks (2 g Cr/day) in hemodialysis patients.  Participants were already being treated with 
vitamins B6, B12 and folate for their condition.  The authors found that their supplementation 
protocol did not further reduce plasma concentrations of Hcy. 
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However, Korzun (2004) reported a statistically significant decrease in plasma Hcy 
concentration in healthy volunteers following four weeks of multivitamin and creatine 
supplementation (twice their urinary creatinine excretion).  Four of the eight participants 
supplementing with creatine experienced decreases of 18 to 27 percent of their baseline Hcy 
concentration. 
The participants in the current study may not have experienced a decrease in their Hcy 
concentration because the supplementation period was not long enough (five days vs. four 
weeks).  The participants in Korzun‟s (2004) study were taking a single dose of creatine that was 
slightly greater than each of the four doses taken by the vegetarians and non-vegetarians in the 
current study.  Baseline Hcy concentrations were comparable, though concentrations were 
slightly less in the current study, which may have been a factor (6 ± 2 vs. 7.1 ± 1.8 µmol/L).  
Korzun (2004) reported a decrease of 0.9 ± 0.7 µmol/L.  This post-intervention concentration 
remains greater than the starting point for the vegetarians and non-vegetarians in the present 
study. 
While Korzun (2004) appears to be the sole researcher to have found a statistically 
significant decrease in plasma Hcy concentration in humans, animal research has produced 
similar results.  Taes and colleagues (2003) reported a decrease in plasma Hcy concentration in 
an animal model of uremia.  However, other attempts at decreasing the concentration in humans 
have failed (Taes et al., 2004).  Due to these conflicting results, it is difficult to say whether 
plasma or serum Hcy concentrations are altered by the ingestion of creatine monohydrate.  In the 
present study, healthy females did not respond to creatine supplementation with a decrease in 
serum Hcy concentration. 
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The amount of supplemented creatine may not have been large enough to bring about a 
change.  Participants supplemented with 11.42 ± 1.10 g of creatine a day, or 0.25 grams per 
kilogram of LBM (Burke et al., 2003).  Burke et al. (2003) found that this supplementation 
protocol resulted in the least urinary creatine output during a loading phase.  This indicates that 
participants had available to them the maximum amount of creatine with which to suppress 
endogenous production of creatine and therefore the reformation of Hcy.  A supplementation 
protocol of 20 grams of creatine each day is also widely accepted (Greenhaff et al., 1994; Harris 
et al., 1992), and may have been more effective in having an effect on serum Hcy concentration. 
There was, however, an impact of creatine supplementation on plasma concentrations of 
vitamin B6.  Though there was not a significant effect of diet, there was a trend towards a time by 
diet interaction. This would indicate that the dietary groups changed differently.  The mean 
increase in vegetarians was approximately 10 nmol/L, whereas non-vegetarians increased by 
approximately 30nmol/L.  When groups were pooled, concentrations increased following the 
intervention.  This was unexpected, since creatine is not known to have an effect on vitamin B6.  
While previous research has reported that increases in estrogen are associated with a decrease in 
plasma concentrations of vitamin B6 (Rose, 1978), it is unlikely that this was a factor in the 
findings of the current study since plasma concentrations of B6 actually increased as the 
participants moved into the follicular phase and therefore experienced increases in estradiol 
concentration. 
The lack of Hcy response was not a result of a deficiency of creatine uptake.  As 
mentioned, urinary creatine output increased in response to the supplementation protocol.  
Urinary creatine output is used as an indicator of the amount of creatine retained in the body 
(Burke et al., 2001).  Improvements on strength and anaerobic test performances corresponding 
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with creatine supplementation are likely due to increases in muscle creatine stores.  Although 
muscle total creatine was not measured in the current study, urinary creatine measures taken 
from 24 hour urine samples did show a tenfold increase in vegetarians and an eightfold increase 
in non-vegetarians. 
Burke et al. (2001) reported an increase in urinary creatine output of approximately 
twenty-four times the baseline output following supplementation. This approximates 50 % 
creatine retention.  The authors had twenty male varsity athletes supplement with 0.1 grams of 
creatine per kilogram of LBM for a period of seven days.  The athletes had a mean body mass of 
91 ± 21 kg, approximately 30 kg greater than those involved in the current study.  The lower 
levels of urinary creatine output observed in the current study may have been a result of a greater 
uptake and retention rate.  This may be due either to lower intake of creatine in food sources, or 
lower baseline concentration in muscle.  Burke et al. (2001) suggest that their participants had 
maximal concentration of creatine in their muscles at the onset of the study, thereby prohibiting 
further uptake with supplementation, which may also account for the differences in urinary 
creatine output with the current study. 
In the current study, differences in baseline urinary creatine output were expected, but not 
found.  Burke et al. (2003) looked at urinary creatine output and muscle total creatine content in 
vegetarian and non-vegetarian participants before and after eight weeks of creatine 
supplementation (7 day loading, 7 week maintenance dose) and resistance training (8 week 
program).  Participants collected 24 hour urine samples prior to supplementation, on the fifth day 
of supplementation, and following the eight week supplementation period.  Urinalysis revealed 
that baseline concentration of urinary creatine was greater for non-vegetarian participants, as was 
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expected, due to the nature of a vegetarian diet, lacking animal meats and therefore excluding 
most sources of creatine (Burke et al., 2003). 
Urinary creatinine concentration in the current study was not different across groups or 
time. This lack of difference may have occurred because there were no significant differences in 
body mass observed between groups at either time point, and these concentrations are based on 
lean tissue mass (Wang, Gallagher, Nelson, Matthews, & Heymsfield, 1996), which was not 
statistically different between groups or over time.  Also, no changes with supplementation were 
expected, since the changes in body mass, while significant, were minimal.  This is in 
accordance with previous research (Burke et al., 2003). 
The secondary purpose of the current study was to determine the effect of creatine 
supplementation on measures of muscle strength, power and anaerobic capacity in female 
vegetarians and non-vegetarians.  No significant effects of diet were found for any of the fitness 
measures, excepting a group by time interaction for strength as assessed by leg press. Therefore 
the data from vegetarians and non-vegetarians were pooled. 
Previous research looking at differences in body composition measures and dietary intake 
in vegetarians and non-vegetarians reported significantly greater body mass for non-vegetarians 
participants (7 kg greater for female participants) (Millet et al., 1989).  In the current study, while 
there were body mass increases in response to the intervention, and differences in percentage 
body fat between groups at both time points, vegetarians and non-vegetarians did not differ in 
mass at either time point, and the magnitude of the increase in body mass in response to creatine 
supplementation was not significantly different between groups.  Also, neither group 
experienced a change in percentage body fat over time.  Therefore, it is unlikely that these 
 75 
 
increases in body mass were due to a significant increase in skeletal muscle mass, as has been 
previously reported (Vandenberghe et al., 1997). 
A reasonable conclusion for this increase in body mass in the absence of a change in 
percentage body fat is that while there may have been a positive change in fat free mass, it was 
coupled with an increase in fat mass as well.  As such, percentage of total mass represented by 
fat remains the same.  There are three possible causes for this increase in body mass: increase in 
fat mass due to juice mix, increase in fluid retention, and increase in protein synthesis. 
Weight gain may have been due to the carbohydrate containing juice mix combined with 
the creatine monohydrate, adding approximately 400 to 500 calories daily.  Because the 
participants were instructed to maintain their dietary habits and physical activity regime prior to 
the supplementation period, these added calories would likely cause an increase of 
approximately 2000 to 2500 calories consumed over the five day loading period.  The 
participants may have decreased their caloric intake to account for the additional intake, though 
they were instructed to maintain their previous eating habits throughout the intervention.  
Approximately 0.32 kilograms of fat mass could have been accumulated in the course of the 
creatine loading phase.  Obviously this small an increase in fat would not be enough to cause a 
significant difference in percentage of body fat, but it does account for most of the mass gained 
on average in vegetarians and non-vegetarians (0.44 kg and 0.37 kg). 
Previous work suggests that creatine supplementation may cause fluid retention by 
skeletal muscle, which would be responsible for weight gain (Balsom, Harridge, Soderlund, 
Sjodin, & Ekblom, 1995), or that creatine may cause an increase in protein synthesis by 
stimulating the rate of myosin heavy chain synthesis (Ingwall, Weiner, Morales, Davis, & 
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Stockdale, 1974).  Vandenberghe and colleagues (1997) reported an increase in body mass 
corresponding with an increase in fat free mass following creatine supplementation in sedentary 
females.  Body mass and composition were not measured directly after the four day creatine 
loading phase (20 g Cr/day), but following five and ten weeks of maintenance supplementation 
(5.0 g Cr/day) coupled with resistance training.  They reported that those in the creatine group 
experienced a greater increase in fat free mass and a trend towards greater body mass and 
decrease in percentage body fat when compared with a placebo group.  The authors suggest that 
creatine supplementation allowed for this increase in fat free mass, and enhanced the benefits of 
resistance training by improving both maximal muscle strength and maximal intermittent arm 
power output (Vandenberghe et al., 1997). 
In a study investigating the effects of creatine supplementation (7 days of 0.25 g Cr/kg 
lean tissue mass/day followed by 7 weeks of 0.0625 g Cr/kg lean tissue mass/day) in vegetarians 
and non-vegetarians participating in an eight week high intensity, heavy load resistance training 
program, Burke et al. (2003) found that vegetarian participants experienced greater lean tissue 
increases when compared to non-vegetarians (2.4 vs. 1.9 kg).  Also, when pooled according to 
supplement and compared to participants supplementing with a placebo, the creatine group 
(vegetarians and non-vegetarians) experienced greater increases in lean tissue mass. 
In the current study, we succeeded in causing an ergogenic response with creatine 
supplementation.  Creatine monohydrate has been studied in depth for its positive effect on 
exercise performance.  Creatine supplementation increases muscle creatine content (Greenhaff et 
al., 1994).  These increases in muscle creatine content may allow for quicker resynthesis of 
phosphocreatine which subsequently allows a longer period of ADP re-phosphorylation 
(Greenhaff et al., 1994).  In the current study, healthy females took part in a five day creatine 
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loading phase (0.25 g Cr/kg LBM) in order to elevate the concentration of creatine in both the 
bloodstream and in muscle.  Though muscle total creatine was not measured, urinary creatine 
output was analyzed, which is closely correlated to uptake of creatine by muscle. 
Previous research investigating uptake of creatine into muscle and phosphocreatine 
resynthesis in response to a five day creatine loading period reported a mean creatine increase of 
15 % in muscle, and by the second minute of recovery the rate of phosphocreatine resynthesis 
was increased by 42 %, though these differences were not significant when comparing time 
points (Greenhaff et al., 1994).  Muscle biopsies were carried out after three maximal 
contractions and electrical stimulation of the knee extensors. 
Smith, Montain, Matott, Zientara, Jolesz and Fielding (1999) investigated the effect of 
creatine supplementation (0.3g Cr/kg/day) and exhaustive exercise on ATP cost.  Baseline 
concentrations of phosphocreatine, resynthesis following single leg extensions completed to 
exhaustion, and hydrolysis were determined.  Following creatine supplementation (0.3g 
Cr/kg/day), resting muscle phosphocreatine increased by 15 %, and phosphocreatine hydrolysis 
during exercise increased by 13 %.  There was no effect of creatine supplementation on 
phosphocreatine resynthesis immediately following exercise.  However, ATP cost was not 
affected by creatine supplementation, suggesting that the availability of phosphocreatine may not 
cause differences in ATP cost of contraction. 
Similar muscular endurance tests were carried out by Burke and colleagues (2003) with a 
group of vegetarian and non-vegetarian participants.  Participants supplemented with 0.25 g 
Cr/kg of lean tissue mass per day for a seven day loading phase, followed by seven weeks of 
maintenance supplementation (0.0625 g Cr/kg of lean tissue mass per day) and resistance 
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training.  Participants completed 50 repetitions of leg extensions and curls at 180 
o
/s on an 
isokinetic dynamometer before and after the supplementation period began.  The authors 
reported a significant group by supplement by time interaction, where vegetarians supplementing 
with creatine experienced an improvement in performance that was statistically greater than all 
other groups.  The authors attribute this improvement to corresponding increases in total muscle 
creatine and phosphocreatine (Burke et al., 2003). 
Vandenberghe and colleagues (1997) had their female participants perform five bouts of 
30 repetitions of bicep curls on an isokinetic dynamometer, separated by two minute rest 
intervals before and after loading, mid and post maintenance supplementation.  The authors used 
the mean torque for the five bouts to represent performance.  While a creatine loading phase was 
insufficient in creating a statistically significant impact on performance, significant differences 
between groups were found following five and ten weeks of maintenance supplementation.  The 
authors suggest that creatine supplementation allowed the participants to continue optimal 
training for a prolonged period of time when compared to the placebo group.  The participants in 
the current study were not introduced to a resistance training protocol for the duration of the five 
day intervention, though were encouraged to continue their regular physical activity regimen.  
During this regimen, the supplemented creatine may have allowed them to prolong their 
activities, which could therefore have an impact on the post intervention performance tests. 
Contrasting research has shown no effect of creatine supplementation on performance on 
an isokinetic dynamometer.  A study that compared the effects of creatine supplementation on 
knee extensor strength using an isokinetic dynamometer in men and women found no significant 
effect of creatine supplementation following a four day creatine loading period (20g Cr/day) 
(Tarnopolsky & MacLennan, 2000).  Participants performed three sets of 10 repetitions of 
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maximal leg extensions with one minute of rest between sets, at an angular velocity of 30 or 180 
o
/s.  No response to creatine supplementation was reported at either velocity. 
There are some major differences between the current study and that of Tarnopolsky and 
MacLennan (2000).  In the current study, participants performed one set of fifty repetitions 
before and after the supplementation protocol.  Thus the availability of creatine in muscle could 
have allowed them to exercise with higher torque outputs for a longer period of time, whereas 
Tarnopolsky and MacLennan (2000) were more interested in strength during shorter sets of leg 
extensions.  Average power increased in the current study, suggesting that participants 
experienced less fatigue when compared to pre testing. 
These results are substantiated by Chrusch and colleagues (2001), who conducted 
muscular endurance and fatigue tests using an isokinetic dynamometer in older men 
supplementing with 0.3 g Cr/kg of body weight per day for five days, which was followed up 
with maintenance supplementation (0.07 g Cr/kg body weight per day) for a total 
supplementation period of 12 weeks.  The authors also implemented a whole body resistance 
training program.  Participants were asked to complete three sets of ten repetitions of leg 
extensions and curls at 60 
o
/s.  Average power was measured.  The authors reported that creatine 
supplementation improved average power during leg extensions and curls.  The authors suggest 
that the lack of improvement in strength and endurance may be due to a lack of statistical power, 
or insufficient time to overcome a learning curve. 
A learning effect too could have played a role in the current study, since most of the 
participants had a very limited experience with an isokinetic dynamometer, despite all having 
experience with the leg extension exercise itself.  Although participants were instructed to warm 
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up with the equipment prior to the test, by the second testing session, they might have been more 
comfortable and familiar with the leg extensions on the dynamometer.  However, due to the high 
level of significance for both peak torque and average power (p = 0.002), we can conclude that 
while there may have been a learning effect, a statistically significant response to creatine 
supplementation exists as well. 
When pooled, the participants in the current study experienced a significant increase in 
strength assessed using a 1RM bench press and leg press test, in response to creatine 
supplementation.  There were no differences in response due to dietary group for strength as 
assessed by bench press.  For leg press, there was a significant group by time interaction, and a 
significant effect of diet on change scores.  Each group experienced an increase in strength 
during this measure, though the vegetarians improved their mean maximal lift by 16 kg, whereas 
non-vegetarians increased by only 3 kg.  However, neither pre nor post measures were 
significantly different.  While there may have been a slight learning effect on the results, most of 
the participants involved had previous experience with both bench and leg press exercises.  
Creatine supplementation likely fueled the improvements in both leg and bench press following 
the creatine loading phase. 
Increases in strength generally accompany creatine supplementation due to increases in 
muscle creatine content, causing a decrease in fatigue rates during exercise, generally allowing 
the individual to maintain physical activity for longer periods of time (Hoffman et al., 2006).  
Due to such a short period of time between pre and post testing, it is unlikely that strength gains 
were due to an increase in training volume allowed by creatine supplementation.  Alternatively, 
previous work suggests that creatine supplementation increases intramuscular concentration of 
phosphocreatine, thereby delaying fatigue during medium to high intensity exercise (Cady, 
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Jones, Lynn, & Newham, 1989) and allowing for work at a higher training load (Chrusch et al., 
2001).  This is a more probable explanation for the gains in strength achieved in the current 
study. 
Many studies report that strength increases when creatine supplementation is combined 
with a resistance training program (Burke et al., 2003; Chrusch et al., 2001; Hoffman et al., 
2006; Vandenberghe et al., 1997).  Participants in the current study likely would have 
experienced a greater increase in strength if maintenance supplementation and a resistance 
training program had been included in the study.  However, we are able to compare the changes 
in the current study to the differences between creatine and placebo groups in the aforementioned 
studies. 
Burke and colleagues (2003) investigated the effects of creatine supplementation (7 day 
loading, 7 week maintenance dose) and resistance training (8 week program) on strength in 
vegetarian and non-vegetarian participants.  They found that when pooled by diet and compared 
by supplement, those supplementing with creatine experienced a greater increase in their 1RM 
bench press, but not leg press.  When bench press differences were compared to those of the 
current study, it is apparent that the resistance training protocol was very effective, as the 
participants of Burke et al. (2003) experienced an increase of approximately 16 kg on their bench 
press when supplementing with creatine, compared to our increase of 6 kg.  The participants 
supplementing with placebo increased their bench press by approximately 9 kg due to the 
resistance training protocol.  Taking this training program into account, the changes in 1RM 
bench press are comparable to the current work.  There were no differences reported between 
vegetarians and non-vegetarians (Burke et al., 2003).  The authors attribute the improvement in 
performance to the ability to increase their training volumes more quickly than those 
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supplementing with placebo, since their creatine group had a greater training volume than the 
placebo group. 
Chrusch and colleagues (2001) looked at the effects of creatine loading (5 days of 0.3 g 
Cr/kg body weight) followed by maintenance supplementation (0.07 g Cr/kg body weight) 
combined with resistance training (12 weeks, 3 times a week) on strength in older males.  The 
authors reported an increase in 1RM leg press.  Following six weeks of supplementation, the 
creatine group increased their 1RM leg press by approximately 35 kg, whereas the placebo group 
improved by only 20 kg.  Following the 12 weeks of supplementation and resistance training, 
this score was increased by another 20 kg for the creatine group, and 15 kg for the placebo 
group.  The difference between groups following the intervention was 20 kg, which is very 
comparable to the increase in the current study.  There were no differences between groups 
(creatine vs. placebo) for bench press measures.  The authors suggest that bench press did not 
increase because the resistance training program had less upper body exercises than lower body.  
An alternate possibility is that the ability of older adults to respond to bench press training may 
be less than lower body training (Chrusch et al., 2001). 
Hoffman and colleagues (2006) looked at the effects of creatine supplementation and a 
four day per week, split routine resistance training program (10.5 g Cr/day for 10 weeks) on a 
number of fitness measures in males (Hoffman et al., 2006).  These measures included strength 
assessed by 1RM tests for bench press and the squat.  The researchers found that both creatine 
and control groups experienced an improvement in each of the strength measures (Hoffman et 
al., 2006).  Those supplementing with creatine experienced a greater increase over time than the 
control group for both bench press and squat, though both groups experienced an increase due to 
the resistance training program.  The creatine group increased their mean 1RM bench press by 
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approximately 15 kilograms, and their squat by approximately 24 kilograms, compared with five 
and seven kilograms for the placebo group.  When the differences are compared to the current 
work (10 and 17 kg), we find that Hoffman et al. (2006) had slightly greater changes in bench 
press, and slightly lower changes for squat than leg press in the current study. 
It is interesting to note that the strength test performances in the current study compare 
very closely to these previous studies that involved supplementing with creatine for many weeks, 
whereas our protocol had only a five day creatine loading period.  It is possible that increases in 
strength due to supplementation are achievable in only a short period of time, though it is likely 
that there was also a learning effect involved in the current study.  Further research should be 
carried out to establish whether this is the case. 
Due to a decrease in the available stores of ATP and phosphocreatine, performance on 
subsequent repetitions of Wingate anaerobic tests decreased, with reductions in peak power from 
trial 1 to 2 and 1 to 3, and in average power from trials 1 to 2, 1 to 3 and 2 to 3.  It was expected 
that creatine supplementation would improve performance and therefore decrease the magnitude 
of power drop on trials 2 and 3, due to increases in phosphocreatine available in muscle for the 
production of ATP (Greenhaff et al., 1994). 
There were improvements in peak power following the supplementation period, although 
the pooled participants did not experience an improvement in average power following the 
intervention.  The increase in peak power with time, and the decrease in performance with 
repetitions fall in line with previous research using repeated bouts of anaerobic activity (Mujika, 
Padiall, Ibanez, Izquierdo, & Gorostiaga, 2000; Preen et al., 2001; Shomrat et al., 2000; 
Tarnopolsky & MacLennan, 2000).  However, contrasting evidence also exists, stating that 
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creatine does not cause such an improvement in performance (Finn et al,. 2001; Hoffman, Stout, 
Falvo, Kang, & Ratamess, 2005; Odland, MacDougall, Tarnopolsky, Elorriaga, & Borgmann, 
1997).  These contrasting reports may be due to differences in protocol, but may also be due to 
the characteristics of the participants at baseline. 
Results for the Wingate anaerobic tests were similar to work performed by Shomrat et al. 
(2000).  Comparisons of the effects of creatine supplementation on maximal exercise 
performance in vegetarians were made, using three repetitions of 20 second Wingate anaerobic 
tests.  The authors found that the intervention affected both vegetarians and non-vegetarians 
similarly (Shomrat et al., 2000).  Vegetarians had significantly lower baseline concentration of 
plasma creatine, and both vegetarians and non-vegetarians experienced similar increases with 
supplementation.  Non-vegetarians experienced a significant increase in peak power output 
following supplementation, while the vegetarians did not differ significantly. 
Generally, research investigating creatine and anaerobic power has examined the 
response in non-vegetarians.  Since there were no differences between vegetarians and non-
vegetarians in the current work, it is possible to make comparisons between the present study and 
these previous studies.  The response to supplementation in the current study falls in line with 
previous work involving repetitions of anaerobic activity (Preen et al., 2001; Tarnopolsky and 
MacLennan, 2000). 
Tarnopolsky and MacLennan (2000) studied the effects of creatine supplementation (4 
days of 20 g Cr/day) on exercise performance in males and females during two repetitions of 30 
second Wingate anaerobic tests, separated by a period of four minutes.  The resistance set for the 
tests was seven percent of the participant‟s mass.  Peak power was significantly higher in the 
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creatine group, while there were no changes in average power.  While this investigation allowed 
a longer period of time between anaerobic test repetitions, a significant increase with creatine 
supplementation was found in both this and the current research, suggesting that an adequate 
amount of phosphocreatine resynthesis had also occurred in the two minute break given.  It is 
possible that with a longer break between tests, the drop in peak power from one trial to the next 
may not have been as great. 
A group of Australian researchers (Preen et al., 2001) studied the effects of creatine 
supplementation on an 80 minute exercise trial including 10 sets of either five or six by six 
second maximal bike sprints, with varying recover times (24, 54, or 84 seconds between sprints).  
The supplementation protocol included five days of creatine loading (20 g/day).  The creatine 
group had a greater increase in total work performed and peak power following set five and eight 
when compared to the placebo group, who did not experience any significant differences with 
time.  In the current study, creatine supplementation resulted in an increase in peak power when 
the trials were pooled.  The creatine group also had increases in total muscle creatine and 
phosphocreatine concentration following supplementation (Preen et al., 2001).  They suggest that 
the increase in peak power and work performed may be due to a greater energy store allowed by 
the increases in muscle phosphocreatine concentration following the creatine intervention. 
5.4 Limitations 
There were a few limitations associated with this study. 
With respect to food diaries, specific instruction to include information about folate or 
vitamin B12 fortification was not given.  This may have resulted in an underestimation of the 
amount of these vitamins actually being included in the diet.  Analysis of dietary intake did not 
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reveal differences in intake of either folate or vitamin B12.  Though non-vegetarians reported a 
mean intake of approximately 1.5 times more vitamin B12 in their food records, the difference 
was not significant. 
Oral contraceptive use in this study was not used as an exclusion criterion.  Those using 
(or not using) oral contraceptives for a period of at least one year were allowed to participate in 
the study. Oral contraceptive use was evenly distributed between the vegetarian and non-
vegetarian groups (p = 0.197), which allows us to conclude that there was no effect on Hcy 
concentration or physical fitness measures over the course of the intervention. 
A familiarization test was not used in the current research.  All individuals stated that 
they were familiar with bench and leg press, as well as leg extensions.  Few of the participants 
had completed repetitions of the Wingate anaerobic test in the past, which may have had an 
effect on the results for this measure.  It is possible that participants who were not familiar with 
the test did not give as great an effort on the post intervention measure, which would have a 
negative impact on the results.  In future work, a familiarization opportunity for all fitness 
measures should be included, to decrease the possibility of non-maximal efforts being recorded, 
and to limit the effect of learning that may take place without familiarization. 
Scheduling and time limitations made it impossible to complete all post measures on all 
participants immediately upon cessation of the loading protocol.  As such, for some participants 
there were several days between the end of the loading period and post fitness measures.  Since 
participants were not supplemented with creatine during the time between the five day loading 
period and their final fitness test day it is possible that this may have resulted in a decrease in 
creatine availability.  This may have resulted in a lesser magnitude of improvement in strength as 
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assessed by 1RM bench and leg press, and performance during repetitions of the Wingate 
anaerobic test.  Finally, there is a possibility for type II error to occur, due to the small sample 
sizes available to us, resulting in less than the 80 % power calculations we were originally 
aiming for (20 vegetarians, 20 non-vegetarians). With a greater sample size, a significant 
interaction between trial and diet for average power measured during the Wingate anaerobic tests 
may have been elicited, as a trend was revealed with the current sample sizes (p = 0.062).  The 
possibility of type I error exists as well due to the number of statistical tests used in determining 
the location of statistical significance. 
5.5 Conclusions 
The current research project is the first to focus on the Hcy response to creatine 
supplementation in female vegetarians and non-vegetarians.  Whether due to the length of the 
supplementation protocol or the low baseline levels found in the participants, there was no effect 
of Cr supplementation on Hcy concentration.  While Korzun (2004) reports statistically 
significant decreases in Hcy in humans following creatine supplementation, the current study, 
and those of others (Taes et al., 2004) failed to find an observable impact.  Due to these 
conflicting results, it remains difficult to say whether creatine supplementation would result in a 
decrease in Hcy concentration in the bloodstream. 
Baseline concentrations of Hcy were quite low in both vegetarian and non-vegetarian 
participants when compared to other healthy individuals (Bissoli et al., 2002; Herrmann et al., 
2001; Hung et al., 2002; Krajcovicova-Kudlackova et al., 2000; Obeid et al., 2002).  These low 
concentrations may also have limited the potential for an effect of creatine supplementation on 
serum Hcy concentration. 
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While vegetarians have been previously reported to have increased Hcy concentrations 
when compared to non-vegetarians (Bissoli et al., 2002; Herrmann et al., 2001; Hung et al., 
2002; Krajcovicova-Kudlackova et al., 2000), which may put them at increased risk of 
developing cardiovascular disease, there are a number of other lifestyle factors that may 
counteract this risk.  These include, but are not limited to healthy physical activity levels, non-
smoking habits, and dietary constituent consumption.  The current vegetarians had significantly 
lower cholesterol intake when compared to non-vegetarian participants, and satisfy the 
Acceptable Macronutrient Distribution Range, which estimates that 20-35 percent of energy 
should be derived from fat (Institute of Medicine of the National Academies, 2006).  
Consequently, while it is of importance to determine the usefulness of creatine supplementation 
on elevated Hcy concentrations, this may have limited direct application to vegetarians.  In 
instances when vegetarians do have elevated Hcy levels, finding treatments may not be as critical 
as they generally have few other risk factors.  In future research, baseline testing of plasma or 
serum Hcy could be performed to determine whether concentrations are elevated prior to an 
intervention, to increase the potential for change. 
Creatine supplementation had a positive effect on fitness performance during 1RM bench 
press and leg press tests, as well as during repeated Wingate anaerobic tests and fifty repetitions 
of a leg extension.  Vegetarian participants responded very similarly to non-vegetarians for all 
fitness measures except strength as assessed by leg press.  In this case, there was a significant 
interaction between diet and time, whereby vegetarians experienced a greater improvement when 
compared to non-vegetarians, when change scores were considered. 
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Research Participant Information and Consent Form 
 
Title: Changes in serum homocysteine and fitness in response to oral creatine supplementation 
in vegetarians and non-vegetarians concurrently supplementing with vitamin B12. 
Investigators: Carol Rodgers, Ph.D., Dean of the College of Kinesiology, University of 
Saskatchewan.  Phone: 306-966-1061; Email: carol.rodgers@usask.ca. 
Vanessa MacCormick, B.Sc., M.Sc. candidate, Student researcher (supervised by Dr. Rodgers) 
College of Kinesiology, University of Saskatchewan.  Phone: 306-966-1123, Email: 
vanessa.maccormick@usask.ca. 
Gordon Zello, Ph.D., College of Pharmacy and Nutrition, University of Saskatchewan.  Phone: 
306-966-5825, Email: gordon.zello@usask.ca. 
Philip D. Chilibeck, Ph.D., College of Kinesiology, University of Saskatchewan.  Phone: 966-
1072, Email: phil.chilibeck@usask.ca. 
 
Sponsorship:  This research is being sponsored by the Saskatchewan Academy of Sports 
Medicine (SASM). 
You are being invited to participate in a research study because we want to determine the effects 
of creatine supplementation on blood homocysteine levels, and exercise performance in 
vegetarians.  Before you decide whether to participate, it is important for you to understand what 
the research involves.  This consent form will tell you about the study, why the research is being 
done, what will happen to you during the study and the possible benefits, risks and discomforts. 
Homocysteine is a compound which is a risk factor for cardiovascular disease and is elevated in 
vegetarians.  Creatine is a compound that is naturally produced in the body, but is also found in 
meat products.  Supplementation with creatine has been shown to lower homocysteine levels in 
some studies.  Because vegetarians do not consume meat, their creatine levels are lower than 
non-vegetarians and supplementation with creatine may have a greater effect.  By providing 
additional creatine through supplementation to the body, the necessity for the body‟s own 
metabolic pathway to produce creatine is lessened. 
If you wish to participate, you will be asked to sign this form.  Your participation is entirely 
voluntary, so it is up to you to decide whether or not to take part in this study.  If you do decide 
to take part in this study, you are free to withdraw at any time without giving any reasons for 
your decision and your refusal to participate will not affect your relationship with any of the 
researchers.  Please take time to read the following information carefully and to discuss it with 
your family, friends, and doctor before you decide. 
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Purpose:  The purpose of the proposed research is to determine whether creatine monohydrate 
has an effect on serum homocysteine levels and fitness measures in females who adhere to a 
vegetarian diet vs. a non-vegetarian diet, and who are supplementing with vitamin B12. 
 
Possible benefits of this study:  It is possible that supplementation with vitamin B12 or creatine 
monohydrate will reduce your serum homocysteine concentrations.  By participating in this 
study you will also have the opportunity to gain information about your body composition and 
fitness levels.  Also, it is possible that with creatine supplementation your strength and anaerobic 
fitness will improve.  These benefits, however, are not guaranteed. 
 
Procedures:  If you agree to participate in the study, the following things will happen: 
Initially, you will be asked to complete a physical activity readiness questionnaire (PAR-Q) that 
will let the researchers know whether participation in fitness testing is an acceptable thing for 
you, based on your current health.  Once this questionnaire is completed and approved, then we 
can carry on with the remainder of the study. 
Each group, the vegetarian group and non-vegetarian group, will supplement with creatine 
monohydrate for a five day loading period, beginning on day two of their menstrual cycle.  Day 
two is defined as the second day of menses, or your period.  You will be “loading” with 0.25 
grams of supplement per kilogram of lean body mass each day.  This loading period will allow 
your body to absorb the maximal amount of creatine in a short time.  These daily supplements 
will be divided into four equal servings and will be mixed with a carbohydrate containing juice 
mix that you will mix with water, and drink.  This should be done every four hours until your 
four servings are finished for that day.  You will receive the supplements in addition to your 
regular diet. 
You will begin taking vitamin B12 four weeks prior to the initiation of the supplementation 
period, in order to ensure that Hcy metabolism is not limited by vitamin B12 intake.  If this 
metabolism were limited, there could be an increase of Hcy in the blood.  Vitamin B12 
supplementation will consist of 24µg tablets to be taken once a day with a meal for the duration 
of the study. 
Before the supplementation begins you will be asked to complete a three day food diary.  By 
completing the food diary, the researchers can determine your average intake of nutrients.  You 
will be asked to continue with your normal diet and physical activity or exercise levels for the 
whole study. 
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Body composition (i.e. lean tissue, fat mass) will be assessed at the beginning and end of the 
study by air displacement plethysmography using a BodPod.  A BodPod calculates the amount of 
lean tissue and fat mass from the amount of air displaced by your body in a sealed chamber, or 
the Pod.  You will be required to change into a swimsuit and will be provided with a swim cap 
for this test.  The BodPod involves sitting quietly in a measuring chamber for two or three 50 
second measurements.  The BodPod measures the amount of air that a person displaces while 
sitting in a chamber, and determines whole body density from the person‟s mass and volume.  
Body fat and lean mass can then be calculated.  From this we can determine your fat and lean 
mass.  The results of this will be given to you at the end of the study. 
Before we begin the supplementation, we need to do some fitness testing and take some blood 
samples for analysis: 
One of the fitness tests that we will do is a VO2max test, which tests your aerobic fitness, or your 
body‟s capability to deliver oxygen to your muscles while you‟re exercising on a treadmill.  
Following test instructions and a warm up, you will be asked to run at a constant speed until you 
cannot maintain either the speed or your running form.  The incline of the treadmill will increase 
each two minutes of the test.  During the test you will breathe into a mouthpiece so that the gas 
composition of your breath can be determined.  This measure will be done prior to the 
supplementation period.  Though the test itself will take only approximately 10 to 15 minutes, 
please allow an hour to become familiar with the procedure and to prepare for the test. 
The second fitness test that we will do is a strength test, where we will need to determine the 
greatest amount of weight you can lift on a bench press and a leg press.  After the process has 
been explained fully, and you have warmed up, a weight will be chosen that is approximately 
20% less than the predicted maximal amount that you can lift.  Two minutes of rest will be given 
between trials, until your maximal weight is determined.  For the bench press, you will lie on an 
exercise bench on your back and grip the bar with your thumbs at shoulder width apart, your 
buttocks in contact with the bench, and the bar starting position even with the top of the chest.  
You will be asked to push the bar to full extension of your arms.  For the leg press test, from a 
sitting position on a leg press machine with your knees bent to a 90 degree position and a flat 
foot on the pedals, the pedals are to be pushed out to full knee extension. 
The third fitness test we will do is called a repeated Wingate test.  This test measures your 
anaerobic fitness, or the ability of your body to work at a very high intensity on a stationary 
bicycle for 30 seconds.  Following a warm up and explanation of the test, you will be asked to 
pedal as hard as possible immediately after the “GO” command is given, and to give an all out 
effort for the 30 seconds of exercise, while remaining seated on the stationary bicycle.  At the 
beginning of the 30 second test, a resistance chosen based on your weight will be applied, while 
pedaling at 80 revolutions per minute (rpm).  Following the test you will be allowed 2 minutes to 
rest while seated on the bicycle, and then the test will be repeated (for a total of three tests).  
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From your performance we can determine changes in mean and peak power, which gives 
information about your anaerobic capacity. 
Another exercise test that will be performed requires you to do 50 knee extensions and flexions 
with maximal effort on a device that measures your force output.  The purpose of this test is to 
measure total work performed by the knee extensors and flexors.  An isokinetic dynamometer 
will be set at a constant speed, and you will be asked to move your lower leg from a bent to 
straight position, or vice versa, while in a seated position.  After a warm up and familiarization 
set of 10 motions, you will be asked to complete 50 repetitions of knee extensions or flexions. 
In order to determine how much of the supplement you are retaining, we will need to analyze 24 
hour urine samples.  These samples must be collect before and after the supplementation period, 
so that we can compare the different concentrations of creatine in your urine.  You will be 
supplied with a urine collection container, and will be asked to collect your urine on the 
particular day beginning with the second urination of the day.  Once the whole 24 hour sample 
has been collected, you can drop it off with the researchers. 
Finally, a trained individual will collect 3 tubes of blood from your arm for analysis, and take a 
finger prick blood sample.  Blood collections, the strength and total work tests and Wingate tests 
will be done twice, prior to and following the creatine loading period.  The strength and Wingate 
tests will take approximately 30 minutes to conduct, and will be done on the same day as the 
blood collections.  The test of work performed will be conducted at least 48 hours after the other 
fitness measures in order to give your muscles time to heal. 
In summary, you will be required to visit the University of Saskatchewan a total of five times.  
Initially we will meet in order to go over the study protocols and answer any questions that you 
have, run the aerobic VO2max test, and to give you your vitamin B12 supplements.  The second 
meeting will be to conduct the body composition, and strength and Wingate tests, and will take 
approximately one hour.  The third meeting will consist of the isokinetic dynamometer test of 
work performed, as well as the blood collections and the distribution of supplement.  This 
meeting will take between 45 minutes and one hour.  Blood collections will occur again during 
the fourth meeting, as will the body composition, strength and Wingate tests, and the final 
meeting will consist of the post measure of the isokinetic dynamometer test of work performed. 
 
Risks and discomforts: Creatine supplementation has been shown to be associated with 
minimal side effects, especially with the low dose given in this study. There have been anecdotal 
reports of increased muscle cramping or muscle pulls during creatine supplementation, but when 
this is compared to subjects receiving placebo, there is no differences in rates of occurrence of 
muscle cramping or pulls. Creatine supplementation has been shown, on two occasions, to 
worsen kidney function in individuals who already had kidney disease. If you have any problems 
with kidney function you should not participate in this study. 
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With blood sampling there is always a risk of bruising or local infection, though with proper 
techniques and an experienced person performing the blood collections, these risks should be 
minimal. 
The exercise tests may cause you some discomfort because they will be performed to exhaustion.  
Injuries that may result include muscle pulls, strains or cramps, but this will be minimized by 
having you perform a proper warm up and stretching before the exercise tests.  There is a 
possibility that you will feel muscle or joint soreness in the days following your exercise testing. 
There may be unknown or unforeseen risks during the study or after the study is completed. 
 
Costs and Reimbursements:  There will be no reimbursements for time commitments or pocket 
expenses such as transportation. 
 
Research-Related Injury:  There will be no cost to you for participation in this study. You will 
not be charged for any research procedures. In the event you become ill or injured as a result of 
participating in this study, necessary medical treatment will be made available at no additional 
cost to you. By signing this document you do not waive any of your legal rights. 
 
Alternatives to this study:  You do not have to participate in this study to have your fitness or 
body composition assessed. You can schedule a fitness assessment in the College of 
Kinesiology, University of Saskatchewan. 
 
Confidentiality:  While absolute confidentiality cannot be guaranteed, every effort to make 
certain that your participation in the study, and information gathered during the study period will 
be kept confidential will be made.  Your identity will be protected, and all data and information 
regarding the study will be kept together, locked in a cabinet in the College of Kinesiology for a 
period of twenty-five years, in the care of the principal investigator, Dr. Carol Rodgers.  All 
reporting of data in presentation or publication format will be done in aggregate form and will 
not refer directly to individual data. 
 
Voluntary Withdrawal:  Your participation in this research is entirely voluntary.  You may 
withdraw from this study at any time.  If you decide to enter the study and to withdraw at any 
time in the future, there will be no penalty or loss of benefits to which you are otherwise entitled.  
 107 
 
If you are a student at the University of Saskatchewan, refusal to participate or withdrawal from 
the study will not affect your academic standing or relationship with University instructors. 
If you choose to enter the study and then decide to withdraw at a later time, all data collected 
about you during your enrolment in the study will be retained for analysis. 
If you have questions concerning the study you can contact Dr. Carol Rodgers (principal 
investigator) at 306-966-1061 or Vanessa MacCormick (student researcher) at 306-966-1123. 
If you have questions about your rights as a research subject, you can contact the Chair of the 
Biomedical Research Ethics Board, c/o Ethics Office, University of Saskatchewan, at (306) 966-
4053. 
We will advise you of any new information that will have a bearing on your decision to continue 
in the study.
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By signing below, I acknowledge that I have read or have had this read to me and that I 
understand the research subject information, the study procedures, and the consent form.  I 
understand that my participation in this study is voluntary, and that we can withdraw from the 
study at any time without penalty.  I have received a copy of the consent form for my own 
purposes. 
 
 
 
 
 
 
 
Participant‟s signature:                                                         Date:                                   . 
 
 
 
Researcher‟s signature:                                                         Date:                                  . 
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APPENDIX IV: Instructions for completion of food diary 
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APPENDIX V: Physical Activity Readiness Questionnaire (PAR-Q) 
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APPENDIX VI: Physical Activity Readiness Medical Examination (PARmed-X) 
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APPENDIX VII: Details of assay protocols 
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B12 Assay, Abbot Laboratories, Abbott Park, IL 
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Folate Assay, Abbott Laboratories, Abbott Park, IL 
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